Skin external composition

A composition combining nicotinamide with alkanediol, glycyrrhizic acid, and amphipathic compounds addresses the challenge of skin irritation and precipitation, enhancing skin permeability and efficacy while maintaining gentleness.

JP2024156904APending Publication Date: 2024-11-06ROHTO PHARM CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
JP2024129753
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2024-08-06
Publication Date
2024-11-06

AI Technical Summary

Technical Problem

Nicotinamide, while effective for promoting skin penetration and providing benefits like anti-aging and whitening, can cause skin irritation and precipitation due to high concentration formulations, and there is a challenge in achieving a balance between enhancing skin permeability and minimizing irritation.

Method used

A composition combining nicotinamide with alkanediol, glycyrrhizic acid or its salt, and amphipathic compounds, along with specific polymers and esters, to enhance skin permeability while reducing irritation and preventing precipitation.

Benefits of technology

The composition effectively promotes skin permeability of nicotinamide, reduces skin irritation, and prevents precipitation, offering a balanced and effective skin care solution.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024156904000001
    Figure 2024156904000001
  • Figure 2024156904000002
    Figure 2024156904000002
  • Figure 2024156904000003
    Figure 2024156904000003
Patent Text Reader

Abstract

To provide a skin external composition that has good permeability and is inhibited from causing skin irritation and precipitating at high temperatures.SOLUTION: A skin external composition is prepared, which contains: (A) nicotinamide; (B) at least one member selected from the group consisting of alkanediols having 5 to 10 carbon atoms, propanediol, diglycerin, and hydroxyalkylurea; and (C) glycyrrhizinic acid, a glycyrrhizinate, or an amphiphilic compound.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a composition for external use on the skin. More specifically, the present invention relates to a composition for external use on the skin containing nicotinamide. The present invention relates to a composition for external use on the skin. [Background technology]

[0002] Nicotinamide is a vitamin that has been used extensively in the skin care field to date. It is an ingredient that is used to promote circulation, as an anti-inflammatory, and to promote ceramide synthesis, and is also effective in improving beauty. It is also known to have whitening, anti-wrinkle and anti-aging effects.

[0003] For example, Patent Document 1 discloses riboflavin, pyridoxine hydrochloride, nicotinamide and A skin whitening agent containing one or more active ingredients selected from the group consisting of calcium anthrate and calcium phosphate has been proposed. It is being done.

[0004] In addition, Patent Document 2 discloses a method for producing a nicotinamide-based amine compound having 2 to 28 carbon atoms. It is characterized in that it contains one or more compounds selected from the group consisting of α-hydroxycarboxylic acid compounds. Cosmetics for preventing skin aging have been proposed. [Prior art documents] [Patent documents]

[0005] [Patent Document 1] JP 2004-217629 A [Patent Document 2] Japanese Patent Application Publication No. 10-130135 Summary of the Invention [Problem to be solved by the invention]

[0006] Nicotinamide is thus a useful ingredient, enhancing skin penetration during use. On the other hand, if we pursue the penetration of active ingredients such as nicotinamide, it may cause stinging. In addition, nicotinamide is irritating and causes problems with cell damage. It is known that nicotinamide-containing preparations have the potential to enhance efficacy by promoting penetration. It is difficult to achieve both high quality and gentleness to the skin (low irritation, low cytotoxicity, etc.).

[0007] The present inventors have discovered a composition containing nicotinamide, which has a skin permeability of nicotinamide. A topical skin composition that achieves both of these properties while maintaining a balance between promoting skin irritation and suppressing skin irritation. However, such compositions contain nicotinamide. Please note that high concentration formulations may cause water to evaporate and precipitate over time. We found this in

[0008] Therefore, the present invention provides a composition for external use on the skin that can simultaneously promote penetration and suppress skin irritation, comprising: Furthermore, even though it contains a high concentration of nicotinamide, precipitation over time due to water evaporation is suppressed. The object of the present invention is to provide a composition for external use on the skin that is [Means for solving the problem]

[0009] As a result of intensive research aimed at solving the above problems, the present inventors have found that nicotinamide, in particular and glycyrrhizic acid or a salt thereof, or an amphiphilic compound. By combining these two ingredients, it is possible to promote the skin permeability of nicotinamide and suppress skin irritation. They further found that precipitation over time can also be suppressed, which led to the completion of the present invention.

[0010] That is, the present invention provides the following compositions for external use on the skin. Section 1. (A) Nicotinamide; (B) Alkanediols having 5 to 10 carbon atoms, propanediol, diglycerol, and hyaluronic acid At least one selected from the group consisting of hydroxyalkylureas; and (C) from the group consisting of glycyrrhizinic acid, salts of glycyrrhizinic acid, and amphiphilic compounds At least one selected A skin topical composition comprising: The amphiphilic compound is a compound represented by the following general formula (I), a phosphorylcholine-containing polymer and divalent carboxylic acid esters, External composition: [ka] (In the formula, Z is a hydrogen atom or a hydroxy compound having 1 to 30 carbon atoms, which has n hydroxy groups. means the residue obtained by removing; AO means an oxyalkylene group having 3 to 4 carbon atoms; EO means an oxyethylene group; BO means an oxyalkylene group having 4 carbon atoms; n is 1 to 9; a, b, and c each represent the average number of moles of AO, EO, and BO added, and are independently 0 to The number is 200. However, a, b, and c cannot all be 0. Also, when n is 2 or more, Each of the multiple a's, b's, and c's may be the same or different. When Z is a hydrogen atom, n is 1. be. In addition, AO and EO may be added randomly or in the form of a block. Section 2. The component (B) is 1,2-pentanediol, 1,2-hexanediol, diglyceride, one or more selected from the group consisting of phosphorus and 1,3-propanediol; The component (C) is glycyrrhizinic acid, a salt of glycyrrhizinic acid, or a glycyrrhizinic acid represented by the general formula (I): The compounds that are used include phosphorylcholine-containing polymers, (eicosanedioic acid / tetradecanediic acid) poly Diglyceryl-10 and bisethoxydiglycol cyclohexanedicarboxylate Item 2. The composition for external application to the skin according to item 1, wherein the composition is one selected from the group consisting of Section 3. The component (B) is composed of 1,2-pentanediol and 1,3-propanediol. One or more selected from the group The component (C) is glycyrrhizinic acid, a salt of glycyrrhizinic acid, and phosphorylcholine. Item 3. The composition for external application to the skin according to item 2, wherein the polymer is one selected from the group consisting of polymers containing the hydroxyl group and the hydroxyl group. Section 4. 4. The composition for external application to skin according to any one of items 1 to 3, wherein the content of component (A) is 3% by mass or more. Section 5. The skin external composition according to any one of items 1 to 4, wherein the total content of paraoxybenzoic acid esters is A composition for external application to the skin, wherein the content is 0.1% by mass or less. Effect of the Invention

[0011] According to the present invention, the skin permeability of nicotinamide is promoted, skin irritation is suppressed, and the skin It is possible to provide a composition for external application to skin in which precipitation is inhibited. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0012] In this specification, the unit of content "mass%" is synonymous with "g / 100 g".

[0013] The composition for external use on the skin of the present invention comprises: (A) Nicotinamide; (B) Alkanediols having 5 to 10 carbon atoms, propanediol, diglycerol, and hyaluronic acid At least one selected from the group consisting of hydroxyalkylureas; and (C) from the group consisting of glycyrrhizinic acid, salts of glycyrrhizinic acid, and amphiphilic compounds at least one selected from the group consisting of phenylalanine, ...

[0014] [(A) Nicotinamide] The nicotinamide contained in the composition for external use on the skin of the present invention is nicotinic acid (vitamin B3 / Nicotinamide is a water-soluble vitamin and is an amide compound of niacin. It may be an extract from a substance, or may be a substance synthesized by a known method. The 17th edition of the Japanese Pharmacopoeia can be used. In addition to improving rough skin, it is also known to inhibit melanin production and have whitening effects.

[0015] In the composition for external use on the skin of the present invention, the content of component (A) in the total amount of the composition is The content of component (A) is appropriately set based on the total amount of the composition. In order to provide sufficient effectiveness in whitening, anti-aging, etc., the content must be 3% by mass or more. is preferable, and more preferably 4% by mass or more, and can be 5% by mass or more. The content of the component (A) is preferably 20% by mass or less, more preferably 20% by mass or less, based on the total amount of the composition. More preferably, it is 15% by mass or less, further preferably, it is 10% by mass or less, and particularly preferably, The content of the component (A) is preferably 3% by mass or less based on the total amount of the composition. % to 20% by mass, more preferably 3% to 15% by mass, and even more preferably 3% by mass The content is preferably from 4% to 8% by mass.

[0016] [(B) C5-10 alkanediol, propanediol, diglycerol, and At least one selected from the group consisting of hydroxyalkyl urea The component (B) contained in the skin topical composition of the present invention is a component that is useful in the fields of medicines, quasi-drugs, and cosmetics. It is a compound commonly used as an ingredient in topical skin preparations.

[0017] From the viewpoint of achieving the effects of the present invention, the component (B) is preferably an alkanediol having 5 to 10 carbon atoms. propanediol, diglycerin, and hydroxyethyl urea. In order to achieve the effects of the present invention remarkably, the component (B) is at least one of 1, 2 -Pentanediol, 1,2-Hexanediol, 1,2-Octanediol, 1,3- propanediol, diglycerin, and hydroxyethyl urea. At least one of the following is preferred: 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,3-propanediol, or diglycerol are more preferred. 1,2-pentanediol, 1,3-propanediol, or diglycerol may also be used. Preferred is 1,2-pentanediol or 1,3-propanediol, particularly preferred. Commercially available products include, but are not limited to, Zemea Select Propane ediol, HYDROLITE-5, HYDROLITE-5 Green (Shimurai (Osaka Organic Chemical Industry Co., Ltd.), KMO-6 (Osaka Organic Chemical Industry Co., Ltd.), Microcare Emollient PTGJ, Microcare Emollient HXD (manufactured by THOR), Diol PD, Diol PD-V (Kyukyu Alcohol Kogyo Co., Ltd.), diglycerin (Sakamoto Pharmaceutical Co., Ltd.) ), Unigri 2 (NOF Corp.), Hydrovance (Akzo Nobel Corp.), etc. are available. Can be used.

[0018] Among the components (B), alkanediols having 5 to 10 carbon atoms exhibit the effects of the present invention remarkably. From this viewpoint, the number of carbon atoms is preferably 5 to 10, more preferably 5 to 8, and further preferably Examples of such alkanediols include 1, 2-pentanediol, 1,2-hexanediol, or 1,2-octanediol is preferred. Preferably, 1,2-pentanediol or 1,2-hexanediol is more preferred. 2-Pentanediol is more preferred.

[0019] Among the components (B), hydroxyalkylurea is a compound that converts the hydrogen atoms of urea into This refers to a compound in which at least one is substituted with a hydroxyalkyl group. From the viewpoint of achieving the above, specific examples of the hydroxyalkyl group include a hydroxyethyl group, Hydroxypropyl group, hydroxybutyl group, dihydroxybutyl group, hydroxypentyl group Examples of the hydroxyalkyl group include a hydroxyalkyl group, a hydroxyhexyl group, and the like. The ethyl group is preferred.

[0020] More specifically, the hydroxyalkylurea is N-(2-hydroxyethyl)urea. Urea, N-(2-hydroxypropyl)urea, N-(3-hydroxypropyl)urea , N-(2,3-dihydroxypropyl)urea, N-(2-hydroxybutyl)urea , N-(3-hydroxybutyl)urea, or N,N'-bis(2-hydroxypropyl) )-N'-(2-hydroxyethyl)urea and the like. The number of hydroxyalkyl groups in the hydroxyalkyl urea is preferably 1 to 3, and more preferably 1 to 2. More preferred is 1 (monohydroxyalkylurea), and even more preferred is 1 (monohydroxyalkylurea). Hydroxyethyl urea is preferred.

[0021] In the present invention, the component (B) may be used alone or in any combination of two or more. They may also be used in combination.

[0022] In the composition for external use on the skin of the present invention, the total content of the component (B) relative to the total amount of the composition is preferably Preferably, it is 0.01% by mass or more, more preferably, 0.1% by mass or more, and even more preferably, More preferably, the content is 0.5% by mass or more, and even more preferably, the content is 1% by mass or more. Particularly preferably, the content of the component (B) is 1.5% by mass or more based on the total amount of the composition. On the other hand, it is preferably 30% by mass or less, more preferably 25% by mass or less, and even more preferably More preferably, the content is 20% by mass or less, even more preferably 15% by mass or less, and particularly preferably 10% by mass or less. The total content of the component (B) is preferably 0.01 to 30 mass %, more preferably 0.01 to 30 mass %. Preferably, the content is 0.1 to 25% by mass, more preferably, 0.5 to 20% by mass, and even more preferably, The content is preferably 1 to 15 mass %, and particularly preferably 1.5 to 15 mass %.

[0023] In the composition for external use on skin of the present invention, the ratio of the total content of component (B) to component (A) is Although not particularly limited, the ratio of the (B) component to 1 part by mass of the (A) component is preferably 0.0 0.01 to 30 parts by mass, more preferably 0.02 to 10 parts by mass, and further preferably 0.01 to 5 parts by mass, even more preferably 0.1 to 5 parts by mass, particularly preferably 0.1 to 4 parts by mass It is a department.

[0024] [(C) component] The component (C) contained in the skin topical composition of the present invention is glycyrrhizinic acid, glycyrrhizin The compound is at least one selected from the group consisting of an acid salt and an amphiphilic compound.

[0025] ((C-1) Glycyrrhizic acid or a salt of glycyrrhizic acid) The glycyrrhizinic acid or salts of glycyrrhizinic acid used in the present invention include pharmaceuticals, Uses compounds that are commonly used as ingredients in pharmaceuticals or cosmetics for skin care products. It is possible.

[0026] In the present invention, the salt of glycyrrhizinic acid is a pharma- ceutically acceptable salt of glycyrrhizinic acid. Examples of suitable salts include, but are not limited to, salts with organic bases (e.g., tertiary amine salts, ammonia salts, etc.). salts with inorganic bases (e.g., inorganic acid salts such as hydrochlorides, sulfates, phosphates, etc.) (Alkali metal salts such as sodium salts, potassium salts, dipotassium salts, etc.) Among these, the preferred salts are monoammonium salts, sodium salts, potassium salts, and dipotassium salts. A salt is preferably a monoammonium salt or a dipotassium salt, and more preferably a monoammonium salt or a dipotassium salt. The preferred salt is the dipotassium salt.

[0027] These can be synthesized, or commercially available products can be used as they are. Examples of suitable glycerol include, but are not limited to, glycerol manufactured by Maruzen Pharmaceutical Co., Ltd. or Alps Pharmaceutical Co., Ltd. Luric acid, dipotassium glycyrrhizinate, dipotassium glycyrrhizinate, glycyrrhizin An example is monoammonium phosphate.

[0028] These glycyrrhizic acids or salts of glycyrrhizic acid may be used alone or in combination of two or more. It can also be used in combination.

[0029] In the composition for external use on the skin of the present invention, the total content of the component (C-1) is not particularly limited, and may be any of the following: B) The amount is appropriately set depending on the type of component and the types of other blended components, but it is possible to significantly enhance the effects of the present invention. From the viewpoint of achieving the above, the content is preferably 0.0001% by mass or more, more preferably 0.0001% by mass or more, based on the total amount of the composition. Preferably, the content is 0.001% by mass or more, more preferably, 0.005% by mass or more, and even more preferably, It is more preferably 0.01 mass % or more, and most preferably 0.05 mass % or more. The total content of the (C-1) component is preferably 5 mass% or less, more preferably 5 mass% or less, based on the total amount of the composition. Preferably, 2% by mass or less, more preferably, 1% by mass or less, and even more preferably, It is preferably 0.5% by mass or less, and most preferably 0.2% by mass or less.

[0030] In the composition for external use on the skin of the present invention, the amount of glycyrrhizinic acid or The total content of the salt of glycyrrhizinic acid is preferably 0.0001 to 5% by mass, more preferably More preferably, it is 0.001 to 2 mass%, more preferably, it is 0.005 to 1 mass%, and even more preferably, it is 0.005 to 1 mass%. Preferably, it is 0.01 to 0.5 mass%, and particularly preferably, it is 0.05 to 0.2 mass%. .

[0031] In the composition for external use on skin of the present invention, (C-1) glycyrrhizinic acid relative to component (A), The ratio of the total content of the salt of glycyrrhizinic acid is not particularly limited, but may be 1% by mass of the component (A). (C-1) glycyrrhizinic acid or a salt of glycyrrhizinic acid is preferably 0.0 to 0.0 parts. 0.000005 to 1.7 parts by weight, more preferably 0.0001 to 0.67 parts by weight, and further Preferably 0.001 to 0.4 parts by mass, and even more preferably 0.002 to 0.1 parts by mass. The content is particularly preferably 0.002 to 0.02 parts by mass.

[0032] ((C-2) Amphiphilic Compound) The amphiphilic compound contained in the skin topical composition as component (C-2) of the present invention is a compound having one molecular weight. Both hydrophilic and hydrophobic groups (lipophilic groups) are present in the molecule, resulting in the incorporation of This refers to all compounds that have affinity for either.

[0033] Such an amphiphilic compound is a compound represented by the following general formula (I): phosphorylcholine and divalent carboxylic acid esters. do. [ka] (In the formula, Z is a hydrogen atom or a hydroxy compound having 1 to 30 carbon atoms, which has n hydroxy groups. means the residue obtained by removing; AO means an oxyalkylene group having 3 to 4 carbon atoms; EO means an oxyethylene group; BO means an oxyalkylene group having 4 carbon atoms; n is 1 to 9; a, b, and c each represent the average number of moles of AO, EO, and BO added, and are independently 0 to The number is 200. However, a, b, and c cannot all be 0. Also, when n is 2 or more, Each of the multiple a's, b's, and c's may be the same or different. When Z is a hydrogen atom, n is 1. be. In addition, AO and EO may be added randomly or in the form of a block. The component (C-2) of the present invention may be any one of these compounds alone or in combination of two or more. The component (C-2) can be used in combination with the components (A) and (B). By doing so, precipitation is suppressed even when a high concentration of nicotinamide is blended. It is therefore possible to provide a composition for external application to the skin that satisfies the above requirements.

[0034] From the viewpoint of providing a good topical skin composition, the alkylene oxide derivative is preferably A compound represented by the following general formula (II) is preferred.

[0035] [ka] (In the formula, Z is a hydrogen atom or a hydroxy compound having 1 to 30 carbon atoms, which has n hydroxy groups. means the residue obtained by removing; AO means an oxyalkylene group having 3 to 4 carbon atoms; EO means an oxyethylene group; n is 1 to 9; a and b each represent the average number of moles of AO and EO added, and are independently 0 to 200. However, a and b cannot all be 0. Also, when n is 2 or more, multiple a and b They may be the same or different. When Z is a hydrogen atom, n is 1. In addition, AO and EO may be added randomly or in the form of a block.

[0036] The alkylene oxide derivative used in the present invention is a polymerizable compound obtained by polymerization of a specific alkylene glycol. (when Z is a hydrogen atom) or a specific hydroxy compound (corresponding to Z) with a specific aryl group. An alkylene oxide group (corresponding to the portion excluding Z in general formulas (I) and (II)) is added (Z is a compound obtained by removing n hydroxy groups from a hydroxy compound having 1 to 30 carbon atoms.) (In the case where the group is a group obtained by

[0037] The alkylene oxide derivative used in the present invention provides a good skin topical composition. From this viewpoint, AO is an oxyalkylene group having 3 to 4 carbon atoms, and examples thereof include oxypro Pyrene group, oxybutylene group (oxy n-butylene group, oxy isobutylene group, oxy t -butylene group), oxytrimethylene group, oxytetramethylene group, etc. is preferably an oxypropylene group, an oxybutylene group, more preferably an oxypropylene group. It is a pyrene group.

[0038] In the alkylene oxide derivative used in the present invention, BO is an oxyalkyl having 4 carbon atoms. Examples of the butylene group include oxybutylene (oxy n-butylene, oxyisobutylene). oxytetramethylene group, etc. are preferably used. It is an oxybutylene group.

[0039] In the alkylene oxide derivative used in the present invention, a, b, and c each independently represent Each of a, b, and c is preferably an integer of 1 to 200. More preferably, it is from 2 to 150, even more preferably from 2 to 100, and particularly preferably Preferably, it is between 2 and 70.

[0040] In chemical formula (I), a+b+c is the total number of AO, EO, and BO monomer units. From the viewpoint of significantly exhibiting the effects of the present invention, it is preferably 3 or more, more preferably 5 or more, More preferably, it is 10 or more. In addition, a+b+c is a value from the viewpoint of exhibiting the effects of the present invention remarkably. , preferably 450 or less, more preferably 350 or less, and even more preferably 300 or less, Particularly preferably, it is 250 or less.

[0041] In the chemical formula (II), the total number of AO and EO monomer units, a+b, is From the viewpoint of exhibiting a remarkable brightness effect, it is preferably 3 or more, more preferably 5 or more, and further preferably It is preferably 10 or more. In addition, a+b is preferably 10 or more from the viewpoint of significantly exhibiting the effects of the present invention. Preferably, the molecular weight is 400 or less, more preferably 300 or less, even more preferably 250 or less, and particularly preferably is less than 200.

[0042] In the above formulas (I) and (II), in order to provide a skin topical composition having good properties, From this viewpoint, Z is a hydrogen atom or an alkyl monoalcohol having 4 to 24 carbon atoms. , glycerin, trimethylolpropane, erythritol, pentaerythritol, carbon Alkyl glucosides with numbers 1 to 24, diglycerin, xylitol, dipentaerythritol from glycerol, sorbitol, inositol, sucrose, trehalose, or maltitol The residue obtained by removing n hydroxy groups, i.e., these aryl groups It is preferably a residue derived from a cole compound, and is a hydrogen atom or a carbon atom. Alkyl monoalcohols having 4 to 24 alkyl groups, glycerin (to which an alkylene oxide group may be added) pentaerythritol (with 3 hydroxy groups to which alkylene oxide groups can be added) hydroxyl groups are 4), alkylglucoside with carbon number 1 to 24 (alkylene oxide group 4 hydroxy groups can be added), diglycerin (alkylene oxide groups can be added) 4 hydroxy groups) or sorbitol (a hydroxy group to which an alkylene oxide group can be added). An oxy group is a residue obtained by removing n hydroxy groups from 6 is more preferred, and is a hydrogen atom or an alkyl monoalcohol having 4 to 24 carbon atoms. Glycerin, alkyl glucoside having 1 to 24 carbon atoms, diglycerin, or sorbitol More preferably, it is a residue obtained by removing n hydroxy groups from It is preferably a hydrogen atom or an alkyl monoalcohol having 4 to 24 carbon atoms, glyceryl glycerol, alkylglucoside having 1 to 24 carbon atoms, or diglycerol with n hydroxyl groups. More preferably, it is a residue obtained by removing an alkyl group having 4 to 24 carbon atoms. Mono alcohol, glycerin, alkyl glucoside with 1 to 5 carbon atoms, or diglyceride It is further preferred that the residue is obtained by removing n hydroxy groups from It is nice.

[0043] In the chemical formula (I) or (II), Z is an alkyl monoalcohol having 4 to 24 carbon atoms. In this case, from the viewpoint of exhibiting the effects of the present invention remarkably, butyl alcohol, decyl tetrahydrofuran, etc. Decyl alcohol, cetanol, and stearyl alcohol are preferred, and butyl alcohol, Decyltetradecyl alcohol is particularly preferred.

[0044] In the chemical formula (I) or (II), when Z is an alkyl glucoside, the effect of the present invention is Among them, alkylglucosides having 1 to 24 carbon atoms are preferred from the viewpoint of significantly exhibiting the above-mentioned properties. Alkyl glucosides having 1 to 16 carbon atoms are more preferred, and alkyl glucosides having 1 to 10 carbon atoms are preferred. is even more preferred, and alkylglucosides having 1 to 6 carbon atoms are particularly preferred.

[0045] Such alkylene oxide derivatives can be synthesized by known methods. For example, Hydroxy compounds having 1 to 30 carbon atoms, ethylene oxide, and alkoxy compounds having 3 to 4 carbon atoms. After addition polymerization of alkylene oxide, it is reacted with alkylene oxide having 4 carbon atoms. In addition, the hydroxy compound having 1 to 30 carbon atoms is mixed with ethylene oxide and In the step of addition polymerization of alkylene oxide having 3 to 4 carbon atoms, ethylene oxide and The alkylene oxide may be randomly polymerized or block polymerized. In the reaction, an alkali catalyst, a phase transfer catalyst, a Lewis acid catalyst, etc. can be used. For this purpose, it is preferable to use an alkali catalyst such as potassium hydroxide.

[0046] The molecular weight of such an alkylene oxide derivative is not limited as long as the effect of the present invention is exhibited. However, from the viewpoint of significantly exhibiting the effects of the present invention, it is preferably 200 or more, and more preferably It is preferably 300 or more, and more preferably 400 or more.

[0047] The properties of the alkylene oxide derivative are not limited as long as the effects of the present invention are exhibited. In the formulas (I) and (II), from the viewpoint of significantly exhibiting the effects of the present invention, preferably, The component is preferably in a semi-solid (including a paste-like form) to liquid form at 25°C.

[0048] In addition, such alkylene oxide derivatives include, for example, polyoxyalkylene glycerides. alkyl ether, polyoxyalkylene alkyl glucoside, polyoxypropylene alkyl polyoxyethylene polyoxypropylene alkyl ether, polyoxyethylene Polyoxypropylene oxybutylene alkyl ether, polyoxyalkylene Rubit, polyoxyalkylene erythritol ether, polyoxyalkylene penta Erythritol ether, polyoxyalkylene diglyceryl ether, polyoxyal Chiral trimethylolpropane, polyoxypropylene glycol, polyoxyethylene Polyoxypropylene glycol, polyoxyalkylene xylitol, polyoxyal Polyoxyalkylene inositol, polyoxyalkylene Trehalose ether, polyoxyalkylene trehalose ether, polyoxyal Examples include kylene maltitol ether.

[0049] Among them, the alkylene oxide derivatives include polyoxyethylene glyceryl ether, poly Oxypropylene glyceryl ether, polyoxyethylene polyoxypropylene glyceryl Ether, Polyoxybutylene Polyoxyethylene Polyoxypropylene Glyceryl Ether, Polyoxybutylene Polyoxyethylene Polyoxypropylene Alkyl Gluco Sid, Polyoxyethylene polyoxypropylene alkyl glucoside, Polyoxyethylene Polyoxypropylene alkyl glucoside, polyoxypropylene alkyl glucoside Polyoxyethylene polyoxypropylene alkyl ether, poly Oxypropylene sorbitol, polyoxyethylene sorbitol, polyoxyethylene polyethylene Oxypropylene sorbitol, polyoxypropylene erythritol ether, polyoxypropylene sorbitol Diethylene erythritol ether, Polyoxyethylene pentaerythritol ether , polyoxyethylene polyoxypropylene erythritol ether, polyoxypropylene Pentaerythritol Ether, Polyoxyethylene Polyoxypropylene Pentaerythritol Ether Ethritol ether, polyoxybutylene polyoxyethylene pentaerythritol ether ether, polyoxyethylene diglyceryl ether, polyoxypropylene diglyceryl Ether, Polyoxyethylene Polyoxypropylene Diglyceryl Ether, Polyoxy Butylene polyoxyethylene polyoxypropylene diglyceryl ether, polyoxyethylene Polyoxypropylene trimethylolpropane, Polyoxypropylene trimethylolpropane, Polyoxypropylene Polyoxyethylene polyoxypropylene trimethylolpropane, polyoxypropylene glycol Coal, Polyoxyethylene Polyoxypropylene Glycol, Polyoxybutylene Poly Oxyethylene polyoxypropylene glycol, polyoxyethylene xylitol, Polyoxypropylene alkylene xylitol, polyoxyethylene polyoxypropylene Xylitol, polyoxyethylene polyoxypropylene dipentaerythritol, poly Oxyethylenedipentaerythritol, polyoxypropyldipentaerythritol, Polyoxyethylene inositol, polyoxypropylene inositol, polyoxyethylene Polyoxypropylene inositol, polyoxyethylene sucrose ether, poly Oxypropylene sucrose ether, polyoxyethylene polyoxypropylene sucrose trehalose ether, polyoxyethylene trehalose ether, polyoxypropylene trehalose treahol ether, polyoxyethylene polyoxypropylene trehalose ether, poly Oxyethylene maltitol ether, polyoxypropylene maltitol ether, and and polyoxyethylene polyoxypropylene maltitol ether. One or more of the following are preferred: Polyoxyethylene glyceryl ether, polyoxypropylene glyceryl ether, Polyoxyethylene polyoxypropylene glyceryl ether, polyoxybutylene poly Oxyethylene polyoxypropylene glyceryl ether, polyoxybutylene polyoxy Diethylene polyoxypropylene alkyl glucoside, polyoxyethylene alkyl glucoside Coside, polyoxypropylene alkyl glucoside, polyoxypropylene diglyceryl Ether, polyoxyethylene diglyceryl ether, polyoxypropylene alkyl ether ether, and polyoxyethylene polyoxypropylene alkyl ether More preferably, one or more selected from the above are selected, such as polyoxyethylene glyceryl ether, Polyoxypropylene glyceryl ether, polyoxyethylene polyoxypropylene glycol Lyceryl ether, polyoxybutylene polyoxyethylene polyoxypropylene glyceryl Ether, Polyoxybutylene Polyoxyethylene Polyoxypropylene Alkyl Glycol Glucoside, Polyoxyethylene methyl glucoside, Polyoxypropylene methyl glucoside , polyoxypropylene diglyceryl ether, polyoxyethylene diglyceryl ether ether, polyoxypropylene alkyl ether, polyoxyethylene polyoxypropylene Indecyl tetradecyl ether and polyoxyethylene polyoxypropylene butyl ether More preferably, it is one or more selected from the group consisting of ethers.

[0050] These can be synthesized, or commercially available products can be used as they are. Examples of suitable materials include, but are not limited to, Unilube 50MB-26 (polyoxyethylene polyoxypropylene). Propylene butyl ether (17E.O.) (17P.O.)), Unilube 50MB-1 68 (Polyoxyethylene polyoxypropylene butyl ether (37E.O.) ( 38P .O.)), Unilube 50MB-11 (Polyoxyethylene polyoxypropylene butyrate Ether (9E.O.) (10P.O.)), Unisafe 10P-8 (Polyoxyethylene Polyoxypropylene cetyl ether (10E.O.) (8P.O.)), Uniru MT-630B (Polyoxyethylene polyoxypropylene decyl tetradecyl ether (30E.O.)(6P.O.)), Sorbure GS-01 (Polyoxyethylene polyethylene Polyoxypropylene decyl tetradecyl ether (24E.O.) (13P.O.)), Unilube MS-70K (Polyoxypropylene stearyl ether (15P.O.)) , Uniol HS-1600D (Polyoxyalkylene Sorbitol), Pronon #208 ( Polyoxyethylene polyoxypropylene glycol (150E.O.) (35P.O. )), Pronon #124P (Polyoxyethylene (20) Polyoxypropylene (20) glycol), Uniol D-2000 (polypropylene glycol), MacBio-Brown MG-10E (Polyoxyethylene methyl glucoside (10E.O.)), Macbio Ride MG-20E (Polyoxyethylene methyl glucoside (20E.O.)), Makubi Obride MG-10P (Polyoxypropylene methyl glucoside (10P.O.), Cubiobride MG-20P (Polyoxypropylene methyl glucoside (20P.O.) ), Wilbride MG2070 (Polyoxybutylene Polyoxyethylene Polyoxyp propylene methyl glucoside), Unilube 5TP-300KB (polyoxyethylene polyethylene Oxypropylene pentaerythritol ether (5E.O.) (65P.O.)); Nilube 50TG-32 (Polyoxyethylene polyoxypropylene glyceryl ether (24E.O.)( 24P.O.)), Wilbride S-753 (Polyoxybutylene Poly Oxyethylene polyoxypropylene glyceryl ether (3B.O.) (8E.O.) ( 5P.O.), Uniox G-1200 (polyoxyethylene glycerin), Unil Unilube DGP-700, Unilube DGP-950 (Polyoxypropylene diglyceryl ether Ether) (all manufactured by NOF Corporation); SY-DP14, SY-DP9 (Polyoxypropyl range glyceryl ether) (both manufactured by Sakamoto Pharmaceutical Co., Ltd.); Newpol GP-1 000 (PPG-16 glyceryl ether), Newpol SP-750 (Polyoxyethylene sorbitol ether), Newpol PE-68 (polyoxyethylene polyoxyethylene Propylene glycol (160E.O.) (30P.O.)), Newpol PE- 78 (Polyoxyethylene polyoxypropylene glycol (150E.O.) (35P .O.)), Newpol GEP-2800 (Polyoxyethylene polyoxypropylene Glyceryl ether (24E.O.) (24P.O.) (both manufactured by Sanyo Chemical Industries, Ltd.) ; Emulgen PP-290 (Polyoxyethylene polyoxypropylene glycol (16 0E.O.)(30P.O.), manufactured by Kao Corporation); NIKKOL SG-G2424( Polyoxyethylene polyoxypropylene glyceryl ether (24E.O.) (24P .O.), NIKKOL SG-DTD630 (Polyoxyethylene polyoxypropylene Indecyl tetradecyl ether (30E.O.) (6P.O.), NIKKOL SG- DTD620 (Polyoxyethylene polyoxypropylene decyl tetradecyl ether ( 20E.O.)(6P.O.)), NIKKOL PEN-4612 (Polyoxyethylene Polyoxypropylene decyl tetradecyl ether (12E.O.) (6P.O.)) (All of these are manufactured by Nikko Chemicals); GLUCAM P-10 (polyoxypropylene methyl glycol) Glucoside (10P.O.)), GLUCAM P-20 (Polyoxypropylene methyl glycol) Glucoside (20P.O.)) GLUCAM E-10 (Polyoxyethylene methylglucoside cyclodextrin (10P.O.)), and GLUCAM E-20 (polyoxyethylene methylglucose One or more selected from the group consisting of Coside (20P.O.) (all manufactured by Lubrizol Corporation) It is preferable that the above is used. Khubiobride MG-10E, Macbiobride MG-20E, Macbiobride MG- 10P, Macbio Bride MG-20P, Wilbride MG2070, Wilbride S-753, Unilube 5TP-300KB, Unilube 50TG-32, Uniox G-1200, Unilube DGP-700, Unilube DGP-950, Newpol G EP-2800, NIKKOL SG-G2424, GLUCAM P-10, GLUC AM P-20, GLUCAM E-10, NIKKOL PEN-4612, NIKK OL SG-DTD620, NIKKOL SG-DTD630, Unilube MT-630B, Sorbure GS-01 and GLUCAM E-20 It is preferable that the compound is one or more selected from the group consisting of the following:

[0051] In the present invention, the alkylene oxide derivatives may be used alone or in combination. Any combination of the above may be used.

[0052] The phosphorylcholine-containing polymer is a polymer obtained by polymerizing an organic compound containing phosphorylcholine as a monomer. Although not particularly limited, from the viewpoint of significantly exhibiting the effects of the present invention, Among them, a monomer containing 2-methacryloyloxyethyl phosphorylcholine is polymerized. The polymer obtained by the above reaction is preferably a 2-methacryloyloxyphosphorylcholine-containing polymer. Among them, 2-methacryloyloxyethyl phosphorylcholine / butyl methacrylate copolymer Polymer (Polyquaternium-51), 2-methacryloyloxyethyl phosphorylcholine Stearyl methacrylate copolymer, 2-methacryloyloxyethyl phosphorylcholine polymer, and polymethacryloyloxyethyl phosphorylcholine polymer. One or more of the above-mentioned are preferred, and 2-methacryloyloxyethyl phosphorylcholine is also preferred. Butyl methacrylate copolymer is more preferable. Lipidure-PMB (2-methacryloyloxyethyl phosphorylcholine -Butyl methacrylate copolymer liquid, Polyquaternium-51), and Lipidure- HM (polymethacryloyloxyethyl phosphorylcholine) (both manufactured by NOF Corp.) and Lipidure-PMB(2-methyl-p-tert-butyl ether) is preferably used. methacrylate copolymer liquid) is more preferred. I wish.

[0053] Dicarboxylic acid esters are compounds that combine dicarboxylic acids with glycols, glycol ethers, etc. It is an ester condensed with a hydroxy group, and is not particularly limited, for example, (eicosane diamine). Polyglyceryl-10, cyclohexanedicarboxylate, bisethoxylated Diglycol, 1,4-cyclohexanedicarboxylic acid bis(triethylene glycol mono Diethylene glycol monoethyl ether), adipate bis(diethylene glycol monoethyl ether), adipate Bis(triethylene glycol monoethyl ether) succinate, and diethoxyethyl succinate diethylhexyl succinate, among which (eicosanedioic acid / tetradecane diacid ) Polyglyceryl-10, bisethoxydiglycol cyclohexanedicarboxylate, succinyl ether Preferred are diethoxyethyl succinate and diethylhexyl succinate, and (eicosanedioic acid / tetraethyl ester) Polyglyceryl-10, cyclohexanedicarboxylate, bisethoxydiglyceryl-10, Cholesteric acid is more preferred, and bis(ethoxydiglycol) cyclohexanedicarboxylate is further preferred. In addition, commercially available products include, but are not limited to, diethoxyethyl succinate. (CRODAMOL DES), Diethylhexyl succinate (CRODAMOL OSU ) (both manufactured by Croda Japan Co., Ltd.), Neosolue-Aqua Neosol ue-AquaS ((eicosanedioic acid / tetradecanedioic acid) polyglyceryl-10), N Eosolue-Aqulio (Bisethoxydiglycol Cyclohexanedicarboxylate ) (both manufactured by Nippon Fine Chemical Co., Ltd.) can be used.

[0054] In the composition for external use on the skin of the present invention, the total content of the component (C-2) is not particularly limited, and may be any of the following: B) The amount is appropriately set depending on the type of component and the types of other blended components, but it is possible to significantly enhance the effects of the present invention. From the viewpoint of achieving the above, the content of the composition is preferably 0.0001% by mass based on the total amount of the composition. More preferably, 0.001% by mass or more, and even more preferably, 0.005% by mass or more. More preferably, the content is 0.05% by mass or more, and particularly preferably, 0.1% by mass or more. be. The total content of the (C-2) component is preferably 20% by mass or less, more preferably 20% by mass or less, based on the total amount of the composition. More preferably, it is 15% by mass or less, even more preferably, it is 12% by mass or less, and even more preferably, it is 15% by mass or less. It is preferably 10% by mass or less, and most preferably 8% by mass or less. The total content of the component (C-2) is preferably 0.0001 to 20% by weight based on the total amount of the composition. % by mass, more preferably 0.001 to 15% by mass, and even more preferably 0.005 to 12% by mass. %, even more preferably 0.05 to 10 mass %, and most preferably 0.1 to 8 mass %. %.

[0055] In the skin topical composition of the present invention, the ratio of the total content of the component (C-2) to the component (A) The ratio is not particularly limited, but it is preferable that the (C-2) component is mixed with 1 part by mass of the (A) component. 0.00001 to 4 parts by mass, more preferably 0.00001 to 3 parts by mass, and even more preferably is 0.001 to 2 parts by mass.

[0056] In the skin topical composition of the present invention, the ratio of the alkylene oxide derivative to the total amount of the composition is The content of the specific ingredient is not particularly limited as long as the effects of the present invention are achieved. The content of the alkylene oxide derivative alone is preferably 0. 0.1% by mass or more, more preferably 0.1% by mass or more, and even more preferably 0.5% by mass or more. That's all. The content of the alkylene oxide derivative alone is preferably 15 to 20% by weight based on the total amount of the composition. % by mass or less, more preferably 10% by mass or less, and even more preferably 8% by mass or less. . The content of the alkylene oxide derivative alone is preferably 0. The content is preferably 0.01 to 15% by mass, more preferably 0.1 to 10% by mass, and even more preferably is 0.5 to 8 mass %, and more preferably 0.5 to 5 mass %.

[0057] In the skin external composition of the present invention, the ratio of the phosphorylcholine-containing polymer to the total amount of the composition is The content is not particularly limited as long as the effects of the present invention are achieved. The content of the phosphorylcholine-containing polymer is preferably 0.00 to the total amount of the composition. 0.01% by mass or more, more preferably 0.001% by mass or more, and even more preferably 0.00 It is 5% by mass or more, and even more preferably 0.01% by mass or more. The content of the phosphorylcholine-containing polymer is preferably 1% by mass based on the total amount of the composition. More preferably, it is 0.5% by mass or less, even more preferably, it is 0.4% by mass or less, and even more preferably, it is 0.5% by mass or less, even more preferably, it is 0.4% by mass or less, and even more preferably, it is 0.5% by mass or less, and ... More preferably, it is 0.2 mass % or less. The content of the phosphorylcholine-containing polymer is preferably 0.00 to the total amount of the composition. 01 to 1 mass%, more preferably 0.001 to 0.5 mass%, and even more preferably 0. The content is preferably 0.005 to 0.4 mass %, and even more preferably 0.01 to 0.2 mass %.

[0058] In the present invention, the component (C) is one or more of the components (C-1) and (C It is also preferable to combine one or more of the components (2).

[0059] Such a combination is, for example, dipotassium glycyrrhizinate (C-1) and C-2) component, polyoxyethylene glyceryl ether, polyoxypropylene glycol Glyceryl ether, polyoxyethylene polyoxypropylene glyceryl ether, poly Oxybutylene polyoxyethylene polyoxypropylene glyceryl ether, polyoxy Butylene polyoxyethylene polyoxypropylene alkyl glucoside, polyoxyethylene Polyoxypropylene methyl glucoside, Polyoxypropylene methyl glucoside, Polyoxypropylene Polyoxyethylene diglyceryl ether, polyoxypropylene Polyoxyethylene polyoxypropylene decyl tetradecyl ether Polyoxyethylene polyoxypropylene butyl ether, 2-methacryloyl Oxyethyl phosphorylcholine-butyl methacrylate copolymer liquid, polymethacryloyl o Dioxyethyl phosphorylcholine, (eicosanedioic acid / tetradecane diacid) polyglyceryl- 10. Bisethoxydiglycol cyclohexanedicarboxylate, diethoxyethyl succinate and diethylhexyl succinate. It is preferable to combine (C-1) Dipotassium glycyrrhizinate and (C-2) Polyoxyethylene Ethylene glyceryl ether, polyoxypropylene glyceryl ether, polyoxyethylene Polyoxypropylene glyceryl ether, polyoxybutylene polyoxyethylene Polyoxypropylene glyceryl ether, polyoxybutylene polyoxyethylene polyethylene Polyoxypropylene alkyl glucoside, polyoxyethylene methyl glucoside, polio Polyoxypropylene methyl glucoside, polyoxyethylene polyoxypropylene decyl tet Polyoxyethylene polyoxypropylene butyl ether, 2-methacrylate Acryloyloxyethyl phosphorylcholine-butyl methacrylate copolymer liquid, (eicosapentaenoic acid Polyglyceryl-10 (tetradecanedicarboxylic acid / tetradecanedicarboxylic acid), bis(cyclohexanedicarboxylic acid) Consists of diethylhexyl succinate, diethylhexyl succinate, and dimethoxydiglycol. It is more preferable to combine one or more selected from the group consisting of the following:

[0060] [Other ingredients] In addition to the above-mentioned essential components, the skin topical composition of the present invention contains other useful functions. Therefore, it is considered to be a component having an effect of preventing and / or repairing DNA damage, as well as a component having an effect of protecting against ultraviolet rays, absorbing ultraviolet rays, and preventing and / or repairing DNA damage. whitening ingredient, anti-inflammatory ingredient, cooling agent, organic acids, anti-glycation ingredient, antibacterial ingredient, cell activation chemical composition Moisture, astringent ingredients, antioxidant ingredients, anti-aging ingredients, moisturizing ingredients, polyhydric alcohol, keratin softening ingredients, Vitamins, blood circulation promoting ingredients, sebum absorbing ingredients, peptides or their derivatives, amino acids or their Various components such as derivatives may be blended in one or in combination of two or more. As the above, those that can be used in the fields of medicines, quasi-drugs, cosmetics, etc. are particularly preferred. There is no limitation, and any one can be appropriately selected and used. If applicable, they may be added as ingredients for any of these functions.

[0061] However, the skin topical composition of the present invention does not contain paraoxybenzoic acid esters (parabens). The amount is preferably 0.1 mass% or less, more preferably 0.01 mass% or less, and more preferably 0.001 mass% or less. Even more preferably, the composition is substantially free of parabens. Oxybenzoic acid esters (parabens) include methyl paraoxybenzoate, Examples include ethyl benzoate, propyl parahydroxybenzoate, and butyl parahydroxybenzoate. .

[0062] Examples of the ultraviolet protection agent include zinc oxide, titanium oxide, iron oxide, cerium oxide, Zirconium oxide, titanium silicate, zinc silicate, anhydrous silicic acid, cerium silicate, hydrous silica Inorganic compounds such as acids, and their derivatives such as hydrous silicic acid, aluminum hydroxide, mica, It is coated with inorganic powder such as talc, or is made of polyamide, polyethylene, polyester, polystyrene, etc. Compounds of resin powder such as polyethylene and nylon, as well as silicone oil and fatty acid aluminum Examples include those treated with zinc salts, alkyl titanates, etc. Among these, zinc oxide, titanium oxide, etc. Inorganic compounds such as tungsten and iron oxide, and the combination of these inorganic compounds with aluminum hydroxide and hydrous silicate Preferably, the material is coated with inorganic powder such as mica or talc, or with silicone oil. When a component is added, its content can be appropriately selected taking into consideration the feel and effect on the skin. For example, about 0.001 to 35% by mass, preferably about The content is 0.1 to 25% by mass.

[0063] The ultraviolet absorbing agent is not limited, but is preferably a salicylic acid-based ultraviolet absorbing agent. agents, cinnamic acid-based UV absorbers, benzoylmethane-based UV absorbers, benzoic acid ester derivatives Body UV absorbers, triazine derivative UV absorbers, benzalmalonate derivative UV absorbers agents, octocrylene-based ultraviolet absorbers, imidazole sulfonic acid derivative ultraviolet absorbers, The ultraviolet absorber may be a zofenone derivative.

[0064] In the present invention, such an ultraviolet absorbing agent is, but not limited to, paramethoxyphenyl. 2-Ethylhexyl cinnamate, 4-tert-butyl-4'-methoxydibenzoyl meth 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoic acid hexyl ester Dimethoxybenzylidene dioxoimidazolidinepropionic acid 2-ethylhexyl , 2,2'-methylenebis[6-(2H-benzotriazol-2yl)-4-(1,1 ,3,3-tetramethylbutyl)phenol], 2,4-bis-[{4-(2-ethylhexyl) xyloxy)-2-hydroxy}-phenyl]-6-(4-methoxyphenyl)-1, 3,5-Triazine, 2,4,6-tris[4-(2-ethylhexyloxycarbonyl )Anilino]-1,3,5-triazine, dimethicone diethyl benzalmalonate, 2-cyclohexyl Ano-3,3-diphenylprop-2-enoic acid 2-ethylhexyl ester, 2-phenyl Benzimidazole-5-sulfonic acid is preferred, and 2-ethyl paramethoxycinnamate is preferred. xyl, 4-tert-butyl-4'-methoxydibenzoylmethane, 2-[4-(diphenyl 2,4-bis(2-hydroxybenzoyl)benzoic acid hexyl ester [{4-(2-ethylhexyloxy)-2-hydroxy}-phenyl]-6-(4-methyl 2,4,6-Tris[4-(2-ethylphenyl)-1,3,5-triazine, [xyloxycarbonyl]anilino]-1,3,5-triazine, 2-phenylbenzoyl Midazole-5-sulfonic acid is more preferred, and 2-ethylhexyl paramethoxycinnamate is more preferred. , 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoic acid hexyl ester 2,4-bis-[{4-(2-ethylhexyloxy)-2-hydroxy}-phenyl 1,3,5-triazine, 2,4,6-tris[ 4-(2-ethylhexyloxycarbonyl)anilino]-1,3,5-triazine is More preferred.

[0065] The ultraviolet absorbing agent may be a commercially available product or may be synthesized.

[0066] Commercially available products include, but are not limited to, Parsol EHS (DSM Nutrition Japan), ESCALOL 587 (Ashland Japan) , EusolexOS (Merck), Parsol HMS (DSM Nutrition (manufactured by BASF), Uvinul MC80 (manufactured by BASF), Parsol MCX (DSM Nutrition Japan), Parsol 1789 (DSM Nutrition Japan) (manufactured by SHON Japan), Ubinal A Plus Granular, Soft Shade D H, Tinosorb M (manufactured by BASF), Milestab 360, Mixxim BB / 100, Tinosorb S (BASF), Uvasorb HEB, Vinal T150 (manufactured by BASF), Heliosun OTZ (O'Laughli DSM Nutrition Industries), Parsol SLX (DSM Nutrition (manufactured by DSM Nutrition Japan), Parsol 340 (manufactured by DSM Nutrition Japan), Esca Roll 597 (Ashland Japan), Parsol HS (DSM Nutrition (manufactured by J.P. Japan), Eusolex232 (manufactured by Merk), NeoHeliopan AP (made by Herman & Reimer), Ubinal M40, Escarole 567 Ashland Japan Co., Ltd.), Ubinal MS40 (BASF), EESORB107 (Cipro) SEESORB100 (manufactured by Shipro Chemicals), SEESORB106 (manufactured by Shipro Chemicals) (manufactured by Seisakusho)

[0067] In the composition for external use on the skin of the present invention, the total content of the ultraviolet absorbing agent is , preferably 1 mass % or more, more preferably 3 mass % or more, and even more preferably 6 mass % or more. The total content of the ultraviolet absorbing agent is preferably 7% by mass or more, and more preferably 7% by mass or more. Preferably, the content is 20% by mass or less, more preferably 15% by mass or less, based on the total amount of the composition. More preferably, the total content of the ultraviolet absorbing agent is 10% by mass or less. Preferably, the content is 1 to 20% by mass, more preferably 3 to 15% by mass, and even more preferably The content is preferably 5 to 10% by mass, and particularly preferably 7 to 10% by mass.

[0068] In the skin topical composition of the present invention, the ratio of the total content of the ultraviolet absorber to the component (A) is not particularly limited, but the amount of the ultraviolet absorber is preferably 0 to 1 part by mass of the (A) component. 0.6 to 2 parts by weight, more preferably 1 to 2 parts by weight, and even more preferably 1.4 to 2 parts by weight It is.

[0069] In addition, these UV protection agents and UV absorbers are compounded, supported, or encapsulated with other components. The combination of these is not particularly limited.

[0070] Examples of components having an effect of preventing and / or repairing DNA damage include those for animals (e.g. , Artemia); components derived from plants (e.g., Cat's Claw); DN A, DNA salts, RNA, RNA salts, and other nucleic acid components. Prevention of DNA damage and / or The content of the ingredient having a repairing effect can be appropriately selected taking into consideration the feel and effect on the skin. However, the amount of the composition for external use on the skin of the present invention is, for example, about 0.001 to 3% by mass, preferably In general, the content is about 0.01 to 1% by mass. When animal or plant ingredients are used, the content is In terms of extracts such as dandelions, the amount is preferably about 0.0 The content is 0001 to 0.1% by mass, and more preferably about 0.0001 to 0.01% by mass.

[0071] Examples of whitening ingredients include placenta, arbutin, kojic acid, ellagic acid, and phytin. Acid, Tranexamic Acid, Rucinol, Chamomilla ET, Hydroquinone, 4-Methoxysalicylic Acid potassium salts of linoleic acid; linoleic acid and its derivatives; ascorbic acid and its salts; ascorbic acid Vitamin C derivatives (sodium ascorbyl phosphate, sodium ascorbyl phosphate, Phosphate Magnesium, Tetra-2-hexyldecanoate Ascorbyl, 2-O-Ethyl Ascorbic acid, 3-O-ethyl ascorbic acid, ascorbic acid glucoside, isostearyl Disodium Allyl Ascorbyl Phosphate, L-Ascorbyl Dipalmitate, Palmitic Acid Trisodium Ascorbyl Phosphate, Glyceryl Ascorbate, Bisglyceryl Ascorbate ascorbic acid, alkylglyceryl ascorbic acid, etc.), vitamin A or its derivatives, bread Vitamins such as beta-lactam and its derivatives are also included. Plant ingredients may be used as whitening ingredients. Examples of such plant ingredients include iris (Iris), Ardisia crenata (Ardisia crenata), and others. Mondo, aloe, acerola, oolong tea, star anise, Scutellaria, Coptis, Hypericum , Lamium, Seaweed, Cucumber, Gardenia, Sophora Root, Chlorella, Rice, Rice Moth, Lizanol, rice bran, rhizome, Japanese pepper, perilla, peony, cnidium, sophae Kuhi, soybean, natto, tea, angelica, calendula, witch hazel, safflower, peony leaf, Coix seed, Asarum, kiwi, black bean, gentian, gentian root, sage, radish , azalea, parsley, holly, pearl barley, hops, thyme, clove, tangerine, licorice , chamomile, prune, meadowsweet, alpinia quinata, barberry, sow Grapefruit, Rosa arborescens, Prickly pear, Lemon, Kiwi, Pine, Neem, Argania spinosa Teachoke, horsetail, field laurel, evening primrose, evening primrose, bilberry, geranium globulus, Hamcho, white willow, saxifrage, centella, rosemary, lavender These plant ingredients are included in the skin topical composition of the present invention. When used in products, the form of the plant component is not particularly limited, but is usually a plant extract (plant extract The plant components can be used in the form of oils, essential oils, etc. The scientific name, alternative name, or herbal medicine name of the plant.

[0072] In the present invention, such whitening ingredients include, but are not limited to, placenta, Arbutin, Kojic Acid, Ellagic Acid, Phytic Acid, Tranexamic Acid, Rucinol, Chamomilla ET, hydroquinone, potassium 4-methoxysalicylic acid, linoleic acid and its derivatives , Ascorbic acid, Sodium ascorbate, Sodium ascorbyl phosphate Ascorbic acid phosphate magnesium, ascorbyl tetra 2-hexyldecanoate Ascorbic Acid, 2-O-Ethyl Ascorbic Acid, 3-O-Ethyl Ascorbic Acid, Ascorbic Acid Glucoside, Vitamin A oil, Iris, Almond, Aloe, Acerola, Ajitsu, Grapefruit , coptis, St. John's wort, white lamb, seaweed, pueraria lobata, chlorella, rice, rice hawthorn Burrs, oryzanol, rice bran, perilla, peony, mulberry bark, soybean, tea, tokin Cinnamon, Hamamelis, Peony, Coix seed, Kiwi, Sage, Parsley, Holly, Pigeon Wheat, hops, thyme, cloves, tangerine, liquorice, chamomile, prunes, meadowsweet Cormorant, Purple bark, Alpinia quinata, Sowberry, Grave fruit, Izayoiba La, thorn pear, lemon, kiwi, pine, neem, artichoke, horsetail, plantain, Evening primrose, evening primrose, bilberry, geranium geranium, glasswort, white willow , saxifrage, centella, rosemary, lavender, Chinese quince, and other plants Preferably, the extract is one or more selected from the group consisting of extracts obtained by extracting Placenta, arbutin, kojic acid, phytic acid, tranexamic acid, hydroquinone, Ascorbic Acid, Sodium Ascorbate, Sodium Ascorbyl Phosphate , Magnesium ascorbyl phosphate, Ascorbic acid tetra 2-hexyldecanoate Ascorbic acid, 2-O-ethyl ascorbic acid, 3-O-ethyl ascorbic acid, ascorbic acid glycerol Lucoside, Iris Root Extract, Almond Oil, Aloe Vera Extract, Acerola Extract, Age Extract, Scutellaria root extract, Hypericum extract, Lamium extract, Seaweed extract, Root extract, chamomile extract, peony extract, mulberry extract, soybean extract, Tea extract, Shirocha extract, Calendula officinalis, Hamamelis, Coix seed, Job's tears extract hop extract, prune extract, licorice extract, oil-soluble licorice extract, meadowsweet Sow extract, Purple caramel extract, Alpinia quinata seed extract, Gravefruit extract, Rosa rosa extract, Lemon extract, Kiwi extract, Pine extract, Neem leaf extract Kiss, artichoke extract, horsetail extract, bark extract, evening primrose extract , Evening Primrose Oil, Bilberry Leaf Extract, Geranium Extract, Salicornia Herb Extract, One selected from the group consisting of willow extract, Centella asiatica extract, and Cornus officinalis fruit extract More preferably, one or more species are used.

[0073] The skin topical composition of the present invention contains a whitening ingredient other than nicotinamide as described above. When blended, the amount of the ingredient can be appropriately selected taking into consideration the feel and effect on the skin. For example, about 0.0003 to 10% by mass, preferably about 0. When using plant extracts, the content is calculated as the amount of the extract. For example, about 0.00001 to 20% by mass, preferably about 0.00001 to 20% by mass, based on the total amount of the composition for external use on skin. The content is about 0.0001 to 15% by mass, and more preferably 0.001 to 10% by mass.

[0074] Anti-inflammatory ingredients include, for example, allantoin, calamine, tranexamic acid, and glycyrrhetinic acid. glycyrrhetinic acid or its derivatives or their salts (e.g., glycyrrhetinic acid, glycyrrhetin stearyl acid, etc.), zinc oxide, aminocaproic acid, azulene and its derivatives (e.g., Guaiazulene, azulene, etc.), tocopherol acetate, pyridoxine hydrochloride, menthol , camphor, turpentine oil, indomethacin, salicylic acid or its derivatives, steroids, or its derivatives or salts (e.g., hydrocortisone, prednisolone), Fenamate, Bufexamac, Ibuprofen Piconol, Glycol Salicylate, Botanical (For example, comfrey, coptis, and dokudami) and the like. Allantoin, tranexamic acid, glycyrrhetinic acid, stearyl glycyrrhetinate , aminocaproic acid, azulene and its derivatives, or Houttuynia cordata extract, Two or more kinds are used, and more preferably, allantoin, tranexamic acid, and aminocaproic acid. When an anti-inflammatory ingredient is added, the content of the ingredient is determined based on the skin condition. The amount of the composition for external use on the skin of the present invention can be appropriately selected taking into consideration the feeling of use and the effect on the skin. For example, the content is about 0.0003 to 10 mass %, preferably about 0.01 to 5 mass %.

[0075] Examples of antibacterial ingredients include chlorhexidine, salicylic acid, benzalkonium chloride, Acrinol, ethanol, benzethonium chloride, cresol, gluconic acid and its derivatives Body, povidone-iodine, potassium iodide, iodine, isopropyl methylphenol, trichloroethylene Rocarban, triclosan, photosensitizer No. 101, photosensitizer No. 201, phenoxyethanol, Alkyldiaminoglycine hydrochloride, cetylpyridinium chloride, piroctoolamine, myconazo alcohol or its salt, chlorobutanol, ethylhexylglycerin, butylcarbamine Propylene iodide, caprylhydroxamic acid, phenethyl alcohol, methylisothiazolinone Zolinone, sorbic acid or its salts, cetyltrimethylammonium bromide, β-glycine Luretin acid, a compound derived from plants (e.g., sophora flavescens, rosemary, mulberry, eucalyptus, etc.) Salicylic acid, benzalkonium chloride, ethanol, chloride, etc. are preferable. Benzethonium, gluconic acid, isopropyl methylphenol, phenoxyethanol, Cetylpyridinium chloride, chlorobutanol, ethylhexylglycerin, butylcarbamate Propylene glycol iodide, caprylhydroxamic acid, potassium sorbate, cetyl bromide Trimethylammonium, β-glycyrrhetinic acid, rosemary extract, eucalyptus extract It is preferable to use one or more selected from the following. When an antibacterial component is used, the content of the component is adjusted to the level of antibacterial activity against the skin. The amount of the composition for external use on the skin of the present invention can be appropriately selected taking into consideration the feeling of use and the effect on the skin. For example, the content is about 0.0003 to 10 mass %, preferably about 0.01 to 5 mass %.

[0076] Examples of the cooling agent include menthol and its derivatives, camphor, borneol, and gelatin. Terpenes such as raniol, cineole, anethole, limonene, and eugenol (these may be in the d-, l- or dl-form; eucalyptus oil, bergamot oil, peppermint oil Mint oil, cool mint oil, spearmint oil, fennel oil, peppermint oil, cinnamon oil, rose Among them, l-menthol, menthyl glyceryl ether, and essential oils such as turpentine oil are particularly preferred. Menthyl lactate, menthyl 3-hydroxybutyrate, menthoxypropanediol Combinations with oleic acid, camphor, eucalyptus oil, peppermint oil, and peppermint oil are preferred.

[0077] Organic acids include gluconic acid, aspartic acid, aminoethylsulfonic acid, and citric acid. , glutamic acid, succinic acid, oxalic acid, fumaric acid, malonic acid, maleic acid, propionic acid , malic acid, salicylic acid, glycolic acid, phytic acid, tartaric acid, acetic acid, lactic acid, pantothenic acid Acid, glycyrrhetinic acid, alginic acid, ascorbic acid, benzoic acid, adipic acid, glutamine Examples of the salts include sulfuric acid, hydrochloric acid, and azelaic acid. Salts of mineral acids such as phosphoric acid, salts of organic acids such as maleic acid or methanesulfonic acid, sodium or Potassium and other alkali metal salts, alkaline earth metal salts, ammonium salts, basic amino acid salts , and amine salts such as triethanolamine. Among them, gluconic acid, citric acid, , glutamic acid, succinic acid, malic acid, salicylic acid, glycolic acid, phytic acid, tartaric acid , lactic acid, glycyrrhetinic acid, and salts thereof. is more preferred.

[0078] Examples of anti-glycation ingredients include Budreja axillaris leaf extract, plum fruit extract, and E. -Delweiss extract, ginkgo extract, cherry leaf extract, pomegranate extract, osmanthus major Coextract, Hawthorn extract, Peony extract, Houttuynia cordata extract, Bilberry leaf Extract, green tea extract, black tea extract, horse chestnut extract, Roman chamomile extract, mugwort extract Plant extracts such as ginger, evening primrose oil, amla fruit, fruit juice or their extracts, L-arginine Examples of such fatty acids include glycerin, L-lysine, hydrolyzed casein, hydrolyzable tannins, and carnosine. When anti-glycation ingredients are included, their content can be appropriately selected taking into consideration the feel and effect on the skin. However, for example, about 0.0003 to 10% by mass based on the total amount of the skin external composition of the present invention. , and preferably about 0.001 to 5 mass %.

[0079] Examples of cell activation components include amino acids such as γ-aminobutyric acid, retinol, Amines, riboflavin, pyridoxine hydrochloride, pantothenic acid pyrroloquinoline quinones, etc. Vitamins: tannins, flavonoids, saponins, allantoin, placenta, proteo Glycan, photosensitizer No. 301, plants (e.g., soybean bilberry, lemongrass, aloe vera) , chlorella, beadle, coix seed, chamomile, Houttuynia cordata, hops, carrots, etc.) Ingredients derived from: Royal jelly, royal jelly extract; whey, yogurt extract, added Examples include whey extracts such as water-decomposed milk proteins, yeast extracts, etc. When the composition is mixed with the skin, the content of the composition can be appropriately selected in consideration of the feel and effect on the skin. For example, about 0.0003 to 10% by mass, preferably about It is about 0.001 to 5 mass %.

[0080] Examples of astringent ingredients include alum, chlorohydroxyaluminum, and aluminum chloride. nium, aluminum allantoin, zinc paraphenolsulfonate, basic aluminum lactate metal salts such as zinc aluminium, zinc sulfate, and potassium aluminium sulfate; plants (e.g., seaweed, tuna, etc.); Im, black tea, oolong tea, green tea, hypericum, witch hazel, loquat, peony, snowdrop Ta, rooibos, astragalus, artichoke, chamomile, eucalyptus, lemon, rosemary Examples of ingredients that can be used include those derived from the herb, scutellaria, and other herbs. The content of the active ingredient can be appropriately selected taking into consideration the feel and effect on the skin. For example, about 0.0003 to 20 mass%, preferably about 0.00 The content is 1 to 10% by mass.

[0081] Examples of the antioxidant include butyl hydroxyanisole and dibutyl hydroxytoluene. Ene, sodium hydrogen sulfite, sodium pyrosulfite, erythorbic acid and its salts, aspartame Corbic acid and its salts, flavonoids, glutathione, glutathione peroxidase, Glutathione-S-transferase, catalase, superoxide dismutase, Thioredoxin, taurine, thiotaurine, hypotaurine, plants (e.g., Hypericum perforatum, Kakkon, bilberry, Scutellaria, passionflower, grapefruit, peony , meadowsweet, perilla, honeysuckle, sage, yarrow, mallow, shimo Morning glory, safflower, clove, Chinese quince, dwarf geranium, loquat, safflower, peonies, and white , eucalyptus, saxifrage, rooibos, lemongrass, soybean, mugwort, evening primrose Contains antioxidants. When the composition is used, the content can be appropriately selected taking into consideration the feel on the skin and the effect of the composition. For example, about 0.00001 to 10% by mass, preferably about 0. The content is 0001 to 5% by mass, and more preferably 0.001 to 5% by mass.

[0082] Anti-aging ingredients include, for example, hydrolyzed soy protein, retinoids (retinol, tinoic acid, retinal, etc.), pangamic acid, ursolic acid, turmeric extract, sphingomyelin Syn derivatives, silicon, silicic acid, N-methyl-L-serine, mevalonolactone, peptides (e.g. caproyl tetrapeptide-3, oligopeptide-24, etc.), plants (e.g. artemisin Chalk, Rosa rosa, seaweed, bilberry, birch, plantain, angelica, Scutellaria, Hypericum, Comfrey, Neem, Wild Rose, Bellflower, Geranium, Bougainvillea Among them, hydrolyzed soy protein, Retinol, Retinol Acetate, Retinol Palmitate, Caprooyl Tetrapeptide 3. Oligopeptide-24, artichoke leaf extract, seaweed extract, bilberry leaf extract Comfrey leaf extract, neem leaf extract, and Geranium globulus extract are preferred. When blending, the content can be appropriately selected taking into consideration the feel on the skin and the effect. For example, about 0.0003 to 10% by mass, preferably about 0.0003 to 10% by mass, based on the total amount of the skin topical composition of the present invention. is about 0.01 to 5 mass %.

[0083] Moisturizing ingredients include, for example, alanine, serine, aspartic acid, glycine, and proline. , hydroxyproline, glucosamine, theanine, arginine, and other amino acids and their derivatives Conductors; polyhydric alcohols such as glycerin, dipropylene glycol, and 1,3-butanediol sorbitol, xylitol, erythritol, maltose-sucrose condensates (glucose sugar alcohols such as xyloligosaccharides (oligosaccharides) and hydrolyzed xylans (xylooligosaccharides); Trehalose, glyceryl glucoside, trehalose; ceramide, glucosylceramide, co Cholesterol, phytosterol, cholesterol derivatives, phytosterol derivatives; Phospholipids such as lecithin and hydrogenated lecithin; NMF-derived components such as urea; collagen, Keratin, chitin, chitosan, etc. and their hydrolysates; hydroxyethylurea A; Plants (e.g., aloe, seaweed, pueraria lobata, chlorella, lemongrass, chamomile, hawthorn) These include ingredients derived from mamelis, tea, perilla, grapefruit, and gynostemma. Among them, glycine, arginine, glycerin, dipropylene glycol, 1, 3-Butanediol, Glycosyltrehalose, Ceramide, Glucosylceramide, Cholesterol sterol, cholesterol derivatives, phytosterol derivatives, hydrogenated lecithin, urea, ;Collagen, elastin, keratin, hydroxyethyl urea, seaweed extract, chamomile Extract, Hamamelis virginiana extract, Gynostemma pentaphyllum extract, or combination of two or more of these extracts. When moisturizing ingredients are used, their content should be determined taking into consideration the feel and effect on the skin. The amount of the external skin composition of the present invention may be appropriately selected taking into consideration the above. The content is 1 to 20% by mass, and preferably about 0.01 to 10% by mass.

[0084] The polyhydric alcohols include diols having 2 to 4 or 11 or more carbon atoms, and polyols having 3 or more hydroxyl groups. Examples of suitable polyhydric alcohols include glycerin, triglycerin, propylene glycol, and the like. Dipropylene glycol, 1,3-butanediol, ethylene glycol Examples include diethylene glycol, isoprene glycol, and 1,3-butylene glycol. Among them, glycerin, propylene glycol, dipropylene glycol, 1,3 -butylene glycol. When alcohol is added, its content should be selected appropriately taking into consideration the skin feel and moisturizing effect. However, the amount is preferably about 0.1 to 20% by mass, based on the total amount of the composition for external use on skin of the present invention. The content is preferably about 0.5 to 15% by mass.

[0085] For example, when lanolin, urea, or other keratin softening ingredients are used, The content can be appropriately selected taking into consideration the feel and effect on the skin. For example, 0.0001 to 50 mass%, preferably about 0.001 to 50 mass%, based on the total amount of % by mass, and more preferably, about 0.01 to 25% by mass.

[0086] Vitamins include, for example, retinol, retinol acetate, and retinol palmitate. , retinol derivatives such as retinol propionate and retinol linoleate, retinal, Retinoic acid, methyl retinoate, ethyl retinoate, retinol retinoate, d -δ-tocopheryl retinoate, α-tocopheryl retinoate, β-tocopheryl retinoate Vitamin A derivatives such as nicotinate; β-, δ-tocopherol, tocopherol nicotinate, acetic acid dl-α-tocopherol, linoleic acid, (linoleic acid / oleic acid) Tocopherol, potassium (ascorbyl / tocopheryl) phosphate, and other vitamin E derivatives; Boflavin, Flavin Mononucleotide, Flavin Adenine Dinucleotide, Riboflavin Riboflavin butyrate, Riboflavin tetrabutyrate, Riboflavin 5'-phosphate Sodium, riboflavin tetranicotinate and other vitamin B2 compounds; nicotinic acid methyl Nicotinic acids other than the above component (A), such as nicotinic acid, nicotinic acid benzyl, etc.; Ascorbyl stearate, disodium isostearyl ascorbyl phosphate, dipalmitoyl L-Ascorbyl phosphate, Ascorbyl tetraisopalmitate (Tetra 2-hexyldecyl Ascorbyl phosphate), Trisodium Ascorbyl Palmitate Phosphate, Ascorbic Acid, Sodium ascorbate, dehydroascorbic acid, sodium ascorbyl phosphate Thorium, Magnesium Ascorbyl Phosphate, Ascorbyl Glucoside, 2 -O-Ethyl Ascorbic Acid, 3-O-Ethyl Ascorbic Acid, Glyceryl Ascorbic Acid Vitamins such as ascorbic acid, bisglyceryl ascorbic acid, and alkylglyceryl ascorbic acid. C group: methylhesperidin, ergocalciferol, cholecalciferol, and other Vitamin D; Vitamin K such as phylloquinone and falnoquinone; thiamine, and their Salts (e.g., dibenzoylthiamine hydrochloride, thiamine hydrochloride, thiamine diphosphate, etc.) Vitamin B1: Pyridoxine hydrochloride, pyridoxine acetate, pyridoxal hydrochloride, 5'- Pyridoxal phosphate, pyridoxamine hydrochloride and other vitamin B6 derivatives, cyanocobalamin, Vitamin B12 such as doxycobalamin and deoxyadenosylcobalamin; folic acid, Folic acids such as folic acid, pantothenic acid, calcium pantothenate, pantothenyl Alcohol (panthenol), D-pantetheine, D-pantethin, coenzyme A, pantothe pantothenic acids such as diethyl ether, calcium pantetheine sulfonate, etc.; biotin , biocytin, and other biotins; carnitine, ferulic acid, α-lipoic acid, ornithine, and other biotins. Tocopherol, γ-oryzanol, pyrroloquinoline quinone, hesperidin and glucosylherperidin Vitamin-like factors such as ubiquinone, ubiquinone, and their salts are also included. Vitamin B, Vitamin C, Vitamin E, Vitamin A, and Vitamin-like Factors A combination of pyridoxine hydrochloride, pantothenyl alcohol (panthenol), and lysine is preferred. Boflavin, cyanocobalamin, dl-α-tocopherol acetate, palmitoyl ascorbate Ascorbyl ester, tetra-2-hexyldecanoate, retinol, palmitic acid Retinol, retinol propionate, retinol acetate, pyrroloquinoline quinone or its derivatives The combination of one or more selected from the group consisting of salts, ubiquinone, and γ-oryzanol is more preferable. When vitamins are added, their content should be determined taking into consideration the feel and effect on the skin. The amount can be appropriately selected, but it is preferably about 0.001 to 3% based on the total amount of the composition for external use on the skin of the present invention. 0 mass%, preferably about 0.01 to 25 mass%, more preferably about 0.01 to 20 mass%. Quantity %.

[0087] Examples of blood circulation promoting ingredients include plants (e.g., ginseng, angelica tree, arnica, etc.) , ginkgo, fennel, laurel, Dutch oak, chamomile, Roman chamomile, Rotthorn, gentian, burdock, rice, hawthorn, shiitake mushroom, European hawthorn, European hawthorn Juniper, Cnidium, Swertia japonica, Thyme, Clove, Chinese ginger, Angelica acutiloba, Peach tree, Spruce, Carrot, garlic, butcher's broom, grape, peony, horse chestnut, melissa, yuzu , coix seed, rosemary, rose hips, tangerine, angelica tree, spruce, peach, apricot, Ingredients derived from walnuts and corn; dl-α-tocopherol acetate, nicotinic acid triglyceride These include copherol, glucosyl hesperidin, and hesperidin. When the composition is mixed with the skin, the content of the composition can be appropriately selected in consideration of the feel and effect on the skin. For example, about 0.00001 to 10% by mass, preferably about 0.00001 to 10% by mass, based on the total amount of the composition for external use on skin. The content is preferably 0.0001 to 5% by mass, and more preferably about 0.001 to 5% by mass. When ingredients are used, the content is calculated as an extract, etc., relative to the total amount of the topical skin composition. For example, about 0.00001 to 20% by mass, preferably about 0.0001 to 15% by mass. and more preferably, 0.001 to 10% by mass.

[0088] Examples of sebum-absorbing components include talc, mica, hydroxyapatite, zinc oxide, Among them, mica, hydroxyapatite, and the like are preferable. In the case where a sebum-absorbing component is blended, the preferred is mica. In this case, the content can be appropriately selected taking into consideration the feel and effect on the skin. For example, about 0.001 to 35% by mass, preferably about 0.1 to 35% by mass, based on the total amount of the composition. It is 25% by mass.

[0089] Examples of peptides or derivatives thereof include keratin decomposition peptides and hydrolyzed keratin. , collagen, fish-derived collagen, atelocollagen, succinylated atelocollagen, Gelatin, elastin, elastin decomposition peptides, collagen decomposition peptides, hydrolyzed collagen collagen, hydroxypropylammonium chloride hydrolyzed collagen, elastin hydrolyzed pe Peptide, conchiolin hydrolyzed peptide, hydrolyzed conchiolin, silk protein hydrolyzed peptide, Hydrolyzed silk, sodium lauroyl hydrolyzed silk, soy protein hydrolyzed peptide, dehydrated Soy protein, wheat protein, wheat proteolysis peptides, hydrolyzed wheat protein, casein hydrolysis peptides , acylated peptides (palmitoyl oligopeptide, palmitoyl pentapeptide, palmitoyl Among them, keratin hydrolysis peptides, hydrolysis peptides, etc. Keratin, fish-derived collagen elastin, elastin decomposition peptide, collagen decomposition peptide Tide, hydrolyzed collagen, succinylated atelocollagen, elastin hydrolysis peptide, One or two selected from hydrolyzed silk, soy protein hydrolyzed peptide, and hydrolyzed soy protein The combination of the above is more preferable. When a peptide or its derivative is blended, the content The amount of the composition for external use on the skin of the present invention can be appropriately selected taking into consideration the feel and effect on the skin. For example, about 0.0001 to 35 mass%, preferably about 0.001 to 10 mass%, Quantity %.

[0090] Examples of amino acids or derivatives thereof include betaine (trimethylglycine), proline, , hydroxyproline, arginine, lysine, serine, glycine, alanine, phenyl Alanine, β-alanine, threonine, glutamic acid, glutamine, asparagine, aspartate Paragic acid, cysteine, cystine, methionine, leucine, isoleucine, valine, hyaluronic acid Styridine, threonine, tyrosine, taurine, γ-aminobutyric acid, γ-amino-β-hydroxybutyric acid Butyric acid, carnitine, carnosine, creatine, epsilon aminocaproic acid, tripeptide Tophan, Ornithine, Sodium N-Stearoyl-L-Glutamate, Dilaurami Lysine glutamate and its salts, di(phytosteryl / octyl) lauroyl glutamate dodecyl), di(octyldodecyl / phytosteryl / behenyl) lauroyl glutamate In addition, these amino acids or derivatives thereof may be in the form of solvates such as hydrates. The amino acid may be in the d-form, the l-form, or the dl-form. One or more selected from derivatives are preferred.

[0091] In particular, the skin topical composition of the present invention contains acidic hyaluronic acids and heparinoids. Preferably, a copolysaccharide is included.

[0092] Hyaluronic acid extracted from animal tissues and microorganisms generally has an average molecular weight of about 10 The molecular weight of the polymer is said to be over 100,000 and is known to be extremely high. Hyaluronic acid of molecular weight may be used, or high molecular weight hyaluronic acid may be decomposed and fermented by microorganisms. Low molecular weight hyaluronic acid and hyaluronic acid oligosaccharides (tetrasaccharides, hexasaccharides, octasaccharides, etc.) obtained by the above method Using unsaturated hyaluronic acid (having double bonds at the 4th and 5th positions of D-glucuronic acid), Good too.

[0093] Salts of hyaluronic acid or its derivatives are also usable, as long as they are pharmacologically or physiologically acceptable. Examples of the metals include, but are not limited to, alkali metals such as sodium and potassium, calcium, magnesium, etc. Examples of the salt include salts with alkaline earth metals such as sodium and salts with metals such as aluminum. Preferably, the salt of hyaluronic acid or a derivative thereof is a sodium salt, a potassium salt, Alternatively, a zinc salt may be used. Such hyaluronic acid and its derivatives, as well as their salts, are being developed as pharmaceutical and cosmetic raw materials. Therefore, such commercially available products can be used.

[0094] Heparinoids are a general term for polysulfated mucopolysaccharides such as chondroitin polysulfate. 0.5 to 5 molecules on average, preferably 0.6 to 3 molecules on average, per one monosaccharide molecule constituting the copolysaccharide More specifically, the heparinoid is heparin, conjugate, or the like. Contains chondroitin sulfate D and chondroitin sulfate E, also known as droitin polysulfate. do.

[0095] Heparinoids can also be obtained by sulfated mucopolysaccharides, and are derived from bovine and bronchial Extraction and purification are performed using aqueous carriers from the internal organs of animals, including the bronchi, such as mice, and then, if necessary, Such heparinoids can also be obtained by sulfation, depending on the case. Since it has been developed as a cosmetic ingredient, such commercially available products can also be used.

[0096] In the present invention, the acidic mucopolysaccharides include, but are not limited to, hyaluronic acid, low molecular weight Hyaluronic acid, hyaluronic acid oligosaccharide (tetrasaccharide), acetylated hyaluronic acid, cationic hyaluronic acid Alkyl hyaluronate, hydrolyzed hyaluronic acid alkyl (C12-13) glyceryl, cross-linked hyaluronic acid Hyaluronic acid, carboxymethyl hyaluronic acid, alkylene glycol hyaluronate, hyaluronan Dimethylsilanol phosphate, heparinoids and / or salts thereof are preferred, and hyaluronan is preferred. Hyaluronic acid, low molecular weight hyaluronic acid, acetylated hyaluronic acid, hydroxypropyl hyaluronic acid Rutrimonium, Carboxymethyl Hyaluronic Acid, Propylene Glycol Hyaluronate, Sodium hyaluronate, zinc hyaluronate, low molecular weight zinc hyaluronate, acetylated hyaluronate sodium hyaluronate, sodium hyaluronate crosspolymer, and heparinoids More preferably, sodium hyaluronate, zinc hyaluronate, low molecular weight zinc hyaluronate, Acetylated hyaluronic acid, hydroxypropyltrimonium hyaluronate, hyaluronic acid Propylene glycol, sodium hyaluronate crosspolymer, and heparinoids In the case where an acidic mucopolysaccharide is added, the content of the acidic mucopolysaccharide is preferably adjusted so as to provide a good feeling on the skin when used. The amount of the composition for external use on the skin of the present invention can be appropriately selected taking into consideration the effect and the amount of the active ingredient. The content is 0.0001 to 1% by mass, and preferably 0.001 to 0.5% by mass.

[0097] In addition to the above-mentioned components, the skin topical composition of the present invention may further contain the following components depending on its application or formulation: Ingredients that are commonly used in the fields of pharmaceuticals, quasi-drugs, cosmetics, etc. may be appropriately blended. The ingredients that can be added are not particularly limited, but may be, for example, a base or carrier, a surfactant, etc. , thickener, antioxidant, preservative, pH adjuster, chelating agent, stabilizer, irritation reducer Additives such as coloring agents, dispersants, and fragrances can be added. They can be used alone or in any combination of two or more. The amount can be appropriately determined within a range known in the art without impairing the effects of the present invention. In addition, any of the following components may be used as a component for any of the functions listed below. It can be added.

[0098] The base or carrier may be an aqueous base such as water; liquid paraffin, liquid isoparaffin, or sucrose. Quaran, Vaseline, Paraffin, Microcrystalline Wax, Polybutene, Polyethylene Ethylene powder, gelling hydrocarbons (Plastibase, etc.), ozokerite, α-olefin oligomer Hydrocarbons such as methyl polysiloxane, light liquid paraffin, and light iso-liquid paraffin; Methylpolysiloxane, crosslinked methylpolysiloxane, highly polymerized methylpolysiloxane, methylphenyl Phenyl-modified silicones such as polysiloxanes, cyclic silicones such as decamethylcyclopentasiloxane, etc. Silicone, methyl hydrogen polysiloxane, methyl trimethicone, dimethicone Alkyl-modified silicones such as dimethiconol crosspolymer and caprylyl methicone, Crosslinked alkyl-modified silicone, amino-modified silicone, polyether-modified silicone, Polyglycerin modified silicone, cross-linked polyether modified silicone, cross-linked alkylpoly Polyether-modified silicone, silicone / alkyl chain co-modified polyether-modified silicone , silicone / alkyl chain co-modified polyglycerin modified silicone, polyether modified branched Silicone, polyglycerin modified branched silicone, acrylic silicone, phenyl modified silicone Silicone oils such as corn and silicone resins; cetanol, cetostearyl alcohol , stearyl alcohol, behenyl alcohol, octyldodecanol, isostearyl higher alcohols such as sterols, phytosterols, and cholesterol; isosterols; Such as phosphoric acid, lauric acid, myristic acid, palmitic acid, stearic acid, and behenic acid. Higher fatty acids; ethyl cellulose, hydroxypropyl cellulose, hydroxyethyl cellulose cellulose derivatives such as hydroxypropyl methylcellulose; polyvinyl Pyrrolidone;Polyvinyl butyrate;Polyethylene glycol;Dioxane;Butylene glycol Lithium adipic acid polyester; Isopropyl myristate, Octyl myristate Decyl, isopropyl palmitate, cetyl palmitate, isononyl isononanoate, Diisopropyl dipic acid, decyl oleate, isodecyl oleate, dimethyl octane Hexyldecyl Sebacate, Diisopropyl Sebacate, Di-2-ethylhexyl Sebacate, 2-Hexyldecyl lysate, 2-Hexyldecyl palmitate, diisopropyl adipate L-pyr, isotridecyl isononanoate, cetyl lactate, isostearyl isostearate, 12-Hydroxystearate, Cholesteryl Stearate, Co-Oleate Resteryl, Phytosteryl Macadamiate, Phytosteryl Oleate, Pal Dextrin mitate, inulin stearate, hydrogenated jojoba oil, di-2-ethylhexyl Ethylene glycol silylates, dipentaerythritol fatty acid esters, neodicaprate Pentyl glycol, tri(2-ethylhexyl) trimellitate, tridecyl trimellitate Trimethylolpropane, Tri-2-ethylhexyl acid, Trimethylolpropane triisostearate Tyrolpropane, tetra-2-ethylhexanoic acid pentaerythritol, tri-2-ethylhexanoic acid Glyceryl ethylhexanoate, Trimethylolpropane triisostearate, Tri(capric acid Caprylic / Capric Triglyceride, Caprylic / Capric / Myristic / Stearate Glyceryl Allanate, Oleyl Oleate, Di(Phytosteryl) Lauroyl Glutamate Lauroyl glutamate (octyldodecyl / phytosteryl) (phytosteryl / behenyl), triethyl citrate, dimer dilinoleic acid (phytosteryl / isostearic acid), Tearyl / Cetyl / Stearyl / Behenyl), Dimer Dilinoleate Dipentaerythrityl Tri-Polyhydroxystearate, Tri(behenic acid / isostearyl) glyceryl esters of glyceryl carboxylate / eicosanedioate; jojoba oil, beeswax, ca Waxes such as nderilla wax, rice bran wax, cotton wax, carnauba wax, lanolin, etc.; avocado Oil, linseed oil, camellia oil, macadamia nut oil, kukui nut oil, hazelnut oil, Corn oil, olive oil, safflower oil, apricot kernel oil, cinnamon oil, jojoba oil, grape oil Ustilago sativa seed oil, sunflower oil, almond oil, shea butter, camellia oil, rapeseed oil, sesame oil, cocoa Fats, coconut oil, hardened coconut oil, palm oil, palm kernel oil, Japan wax kernel oil, Japan wax, wheat germ oil , rice germ oil, rice bran oil, cottonseed oil, soybean oil, peanut oil, tea seed oil, evening primrose oil, shea butter, and other oils and fats Polysaccharides such as dextrin and maltodextrin; carboxyvinyl polymers, alkyl vinyl polymers such as carboxyvinyl polymer modified with ethanol; Lower alcohols such as sorbitol, xylitol, erythritol, mannitol, etc. Sugar alcohols; water, etc. The base or carrier selected from these components includes: They may be used alone or in combination of two or more. The amounts of them to be used are within the skill of the art. When the composition for external use on the skin of the present invention contains water, the content of water is appropriately selected from the known range. The amount of water varies depending on the form of the cosmetic preparation, and is not particularly limited. For example, the amount of water is preferably 5 to 99 mass%, more preferably, The content is preferably 8 to 95% by mass, and more preferably 10 to 90% by mass.

[0099] Examples of surfactants include sorbitan monoisostearate, sorbitan monostearate, Diglycerol sorbitan tetra-2-ethylhexyl ester, sorbitan monophosphate sorbitan monoisostearate, sorbitan monolaurate, etc. Fatty acid esters; Polyoxyethylene monolaurate (20) Sorbitan, monolauryl Polyoxyethylene (80) Sorbitan Monostearate, Polyoxyethylene (20) Monostearate ) Sorbitan, Polyoxyethylene (20) Sorbitan Monooleate, Isostearin Polyoxyethylene (20) sorbitan, olive oil fatty acid sorbitan, etc. Ethylene sorbitan fatty acid esters; glycerin monooleate, glycerin monostearate glycerol fatty acid esters such as monoisostearyl esters, glycerol monomyristate, etc. glyceryl alkyl ethers, monomyristyl glyceryl ether, etc. Diglyceryl monostearate, decaglyceryl decastearate, decaglyceryl Polyglycerol fatty acid esters such as rudeca isostearate and diglyceryl diisostearate Stearates; propylene glycol fatty acid esters such as propylene glycol monostearate Polyoxyethylene hydrogenated castor oil 40, polyoxyethylene hydrogenated castor oil 50, Hydrogenated castor oil such as polyoxyethylene hydrogenated castor oil 60 and polyoxyethylene hydrogenated castor oil 80 Derivatives of coconut oil; polyoxyethylene glycols such as polyoxyethylene monococoyl glyceryl fatty acid Lycerin fatty acid esters; Polyoxyethylene (20) phytosterols, polyoxyethylene Polyethylene (30) Phytosterol, Polyoxyethylene (25) Phytostanol, Poly Hydrogenated polyoxyethylene sterols such as oxyethylene (30) cholestanol terol; sucrose fatty acid ester; ether carboxylate, alkyl phosphate ester, N-Acylamino acid salts, acylated taurates; stearylamine, oleylamine, etc. Amines; Polyoxyethylene-methylpolysiloxane copolymer, Lauryl PEG-9 poly Didimethylsiloxyethyl Dimethicone, PEG-9 Polydimethylsiloxyethyl Dimethicone Silicone surfactants such as lecithin, hydrogenated lecithin, saponin, sarcosine, etc. Examples of surfactants include naturally occurring surfactants such as sodium fumarate, cholesterol, and bile acid. It is possible.

[0100] Examples of thickeners include polyvinyl alcohol, polyvinylpyrrolidone, polyvinyl Vinyl thickeners such as methyl ether or carboxyvinyl polymers; methylcellulose , ethyl cellulose, hydroxyethyl cellulose, hydroxymethyl cellulose, hydroxy Hydroxypropyl cellulose, Hydroxypropyl methylcellulose, Hydrophobized hydroxypropyl propyl methyl cellulose, carboxymethyl cellulose, or carboxyethyl cellulose cellulose-based thickeners such as cellulose or their salts; guar gum, sclerotium gum, tamarind gum, etc. Do gum, xanthan gum, gellan gum, dextran, pectin, pullulan, gelatin , locust bean gum, carrageenan, agar, acrylic acid alkyl methacrylate copolymer Body, sodium polyacrylate, bentonite, dextrin fatty acid ester, dimethyl Distearyl ammonium hectorite, sodium alginate, propylene alginate Glycol ester, polyethylene glycol, macrogol, (hydroxy acrylate Ethyl / sodium acryloyldimethyl taurate copolymer, or (acryloyldimethyl taurate Ammonium uranyl / vinylpyrrolidone copolymers. Gum, acrylic acid alkyl methacrylate copolymer, hydroxyethyl cellulose, hydrochloric acid Hydroxypropyl cellulose, Hydroxypropyl methylcellulose, Hydrophobized hydroxypropyl Pyrmethylcellulose, carboxyvinyl polymer, alkyl acrylate and alkyl methacrylate Polymer, Dimethyl Distearyl Ammonium Hectorite, (Hydroxyethyl Acrylate (Acryloyldimethyltaurine / Na acryloyldimethyltaurine) copolymer, or (Acryloyldimethyltaurine A ammonium / vinylpyrrolidone copolymer is preferred.

[0101] Examples of the antioxidant include dibutylhydroxytoluene and butylhydroxyanisole. Sorbic acid, sodium sulfite, sodium pyrosulfite, ascorbic acid, ascorbic acid tocopherol, tocopherol derivatives, erythorbic acid, erythorbic Sodium phosphate, L-cysteine ​​hydrochloride, ubiquinones such as coenzyme Q10, sesame Lignans such as ginseng, curcumin, capsaicin, gingerol, resveratrol, Examples include cyanine, cyanidin, bilberry extract, and their analogues or derivatives. can be.

[0102] Examples of pH adjusters include inorganic acids (hydrochloric acid, sulfuric acid, etc.), organic acids (lactic acid, sodium lactate, etc.), and citric acid, sodium citrate, succinic acid, sodium succinate, etc.), inorganic bases (potassium hydroxide, sodium hydroxide, etc.), organic bases (triethanolamine, diisopropyl propanolamine, triisopropanolamine, etc.

[0103] Examples of chelating agents include ethylenediaminetetraacetic acid (edetic acid), ethylenediamine Disodium edetate (Japanese Pharmacopoeia, EDTA-2Na, etc.) , potassium salts, etc.), phytic acid, gluconic acid, polyphosphoric acid, metaphosphoric acid, etc. Of these, sodium edetate is preferred.

[0104] Examples of the stabilizer include sodium polyacrylate and dibutylhydroxytoluene. , butyl hydroxyanisole, and the like.

[0105] Examples of irritation reducers include licorice extract, gum arabic, polyvinylpyrrolidone, etc. Some examples include:

[0106] Colorants include pigment grade titanium oxide, zinc oxide, iron oxide, organic pigments, talc, sericite, etc. Examples of suitable mica include chromium oxide, mica, synthetic mica, chromium oxide, and gunjo.

[0107] Powders may also be added to improve the texture or to impart a makeup effect. Boron nitride, silica, alumina, aluminum hydroxide, metal soap, silicone powder, poly methyl methacrylate and the like.

[0108] [pH] The composition for external application to the skin of the present invention may generally have a pH of 2.0 to 9.0. From the viewpoint of low irritation to the skin and mucous membranes and good skin feel, the pH is preferably 3. 0 to 8.5, more preferably pH 4.0 to 8.0, and even more preferably pH 4.5 to 7.5, and even more preferably, the pH is 5.0 to 7.5.

[0109] [Method of manufacturing the composition for external use on skin] The method for producing the composition for external use on the skin of the present invention is not particularly limited, and in addition to the above-mentioned components (A) to (C), The other ingredients mentioned above are appropriately selected and mixed, and emulsified as necessary in a conventional manner to produce the product. It can be constructed.

[0110] [Properties / Formulation] The form of the composition for external use on the skin of the present invention is not particularly limited, and may be liquid, fluid, or semi-solid. The formulation may be, for example, a liquid, a suspension, an emulsion, a cream, Milky lotion, ointment, gel, liniment, lotion, aerosol, non-woven fabric containing medicinal liquid It can be formulated as a sheet or stick soaked in water. Creams, milky lotions, ointments, gels, lotions, sheets made of nonwoven fabric soaked in medicinal liquid, A moisturizing agent is preferably a moisturizing agent, and a cream, a milky lotion, an ointment, or a gel is particularly preferable. In the case of oil-based and aqueous bases, such as in the case of tablets, creams, and ointments, even W / O type products are classified as O The skin topical composition of the present invention may be used in combination with a water-based formulation, but the feeling of use (stickiness, spreadability, moisturizing feeling, etc.) From the standpoint of freshness, penetration, etc., O / W type is more preferable.

[0111] [Application] Specific uses of the composition for external use as a quasi-drug or cosmetic include, for example: Lotion, milky lotion, gel, cream, serum, sunscreen, pack, mask, hand Body cream, body lotion, body cream, cosmetic wipes, sticks as well as face washes, hand soaps, makeup removers, body washes, Cleansing cosmetics such as shampoos, rinses, and treatments, BB creams, etc. Face makeup cosmetics such as face creams, foundations, and makeup bases, lip balms, Lip cosmetics such as lip liner and lip gel; hair rinse and hair treatment , hair conditioner, hair gel, hair mousse, hair mist, hair lotion, Among these, skin care products such as hair styling products are also included. That is, the composition for external use of the present invention is a pharmaceutical product, a quasi-drug product, or a cosmetic product. The formulation of the composition for external application to the skin of the present invention can be the composition for external application to the skin. The same applies to the composition. Also, the base or carrier that can be used, additives, and active ingredients, as well as The preferred ones thereof are the same as those in the case of the topical composition of the present invention.

[0112] [container] The skin topical composition of the present invention is packed in a container of a shape and material appropriately selected according to the purpose and application of the composition. Specific examples of containers include spray types, bottles, etc. Toll type, tube type, jar type, dropper type, dispenser type, Examples of the composition for external application to the skin of the present invention include a stick type, a pouch bag, and a cheer pack. The product can be used in a desirable state from the viewpoint of ease of removal from the container, and therefore is highly This allows for greater freedom in designing formulations containing nicotinamide at a concentration of 0.1% or more. Even with high-concentration nicotinamide-containing formulations, the product can be used in jars, sticks, and sprays. Can be easily used in a wide variety of containers including cartridges, bottles, tubes and dispensers It becomes Noh.

[0113] The container materials are polyethylene terephthalate, polypropylene, polyethylene Polyethylene (HDPE, LDPE, LLDPE, etc.), ABS resin, ethylene vinyl alcohol resin Examples of the material include plastic, polystyrene, glass, and metal (aluminum, etc.). The materials are given various coating treatments taking into consideration strength, flexibility, weather resistance, and stability of the ingredients. These materials can be mixed, combined, or laminated to create container materials. Among them, polypropylene, polyethylene (HDPE, LDPE) PE, LLDPE, etc.), ethylene vinyl alcohol resin, metal (aluminum, etc.) is preferred.

[0114] [How to use etc.] The skin topical composition of the present invention is expected to have the physiological activity of nicotinamide, and is effective in promoting blood circulation and preventing inflammation. It can also be used for whitening, anti-wrinkle, anti-aging, and other skin-care purposes. It is expected to have a skin-whitening effect and is useful as a multi-functional formulation, including as a skin-whitening agent and sunscreen. The skin topical composition of the present invention can be administered once or several times a day depending on the intended use. It can be used in known or customary dosages and administration.

[0115] [Precipitation suppression method, etc.] In another embodiment, the present invention relates to a method for preparing a composition for external use on the skin comprising (A) nicotinamide. It is also possible to provide a method for suppressing the production of nicotinic acid amide; 0 alkanediol, propanediol, diglycerin, and hydroxyalkylurea (C) at least one selected from the group consisting of glycyrrhizic acid, glycyrrhizin By preparing a composition for external use on the skin containing a salt of nicotinic acid or an amphiphilic compound, Increases the skin permeability of acid amides, suppresses irritation, and inhibits precipitation of skin topical compositions can be achieved.

[0116] As used herein, the term "precipitation" refers to, for example, the form in which the composition for external use on the skin of the present invention is formed. However, the components may not appear as solids (e.g. solid precipitates, needle-like crystals, or fuzzy crystals). It may be a visible deposit or may be difficult to detect by visual inspection. The degree of precipitation and the transparency of the solution were checked using a turbidity meter and an ultraviolet, visible, and infrared spectrophotometer (model V-7 For example, in the composition for external use on the skin of the present invention, In some cases, volatile components may precipitate during the evaporation process.

[0117] In the present invention, even when nicotinamide is blended at a high concentration, it evaporates and dries up over time. It is also possible to prevent precipitation. Precipitation on the straw and other parts can be a major problem. After a certain time has passed, the volatile components have evaporated and the solid matter remains. For example, when the preparation is contained in a jar, the screw of the jar The formulation that adheres to the thread of the cap remains as a deposit, which makes it difficult for the thread to close properly. When the formulation is contained in a bottle, tube, or dispenser, If any deposits remain on the mouth of the container, the next time you use it, the deposits will cause a poor sensation and may irritate your skin. In addition, solids may precipitate around the neck of the container and especially in the straw of the dispenser. If any exudate remains, it may cause the formulation to become clogged.

[0118] This solid matter not only forms in the container but also on the skin after application, which can cause skin irritation. This will result in a worsening of the impact and usability.

[0119] According to the present invention, such problems can be prevented, and the composition can be applied to various container shapes, allowing for greater freedom in formulation. This makes it possible to create formulations with high

[0120] Deposition inhibition means preventing, retarding, and reducing such deposition. Such suppression of precipitation prevents clogging of the container outlet when the topical skin composition is packed in a container. Dry solids adhere to the lids of containers such as jars, etc., and adversely affect the usability, appearance, or actual function. This can prevent any adverse effects from occurring. EXAMPLES

[0121] The present invention will now be described in detail with reference to examples, but the present invention is not limited to the following examples. It's not something like that.

[0122] The components used in the examples are as follows:

[0123] 2-Methacryloyloxyethyl phosphorylcholine-Butyl methacrylate copolymer:L ipidure-PMB(BG) (NOF Corporation) Polyoxybutylene polyoxyethylene polyoxypropylene methyl glucoside: Lubride MG2070 (manufactured by NOF Corporation)

[0124] [Skin penetration and irritation test] The compositions of the reference example, reference example, and reference comparative example shown in Table 1 were prepared and then infused into three-dimensional cultured skin. Permeability and cytotoxicity tests were performed.

[0125] (Permeability test) Human 3D cultured epidermis LabCyte EPI-MODEL24 (Japan Ti Transwell for 24 w Add 0.5mL / well of the dedicated assay medium to the bottom of the well plate. The cells were pre-incubated at 37°C (5-10% CO2) for 18-22 hours.

[0126] Then, replace the dedicated assay medium with 0.5 mL of phosphate-buffered saline (PBS). The plate was pre-incubated in a 37°C incubator for 30 minutes. The cells were then replaced with fresh PBS and 0.1 mL of each composition was added directly on top of the cells. The time when the composition was added was set as zero.

[0127] After 240 minutes, 0.3 mL of liquid was sampled from the bottom. The solution was quantified using HPLC, and the permeability coefficient (P) was calculated based on the following formula. The medium, PBS, and composition were all warmed to 37° C. before administration. P = (ΔQ / Δt) × (1 / C0) × (1 / Area) In the above formula, Q represents the amount of permeation (μg), t represents time (min), and ΔQ / Δt represents the permeation rate of nicotinic acid. The amide permeation rate (μg / min) was expressed as the slope of the linear portion of the cumulative drug permeation-time curve. In addition, C0 is the initial concentration of nicotinamide administered (g / mL), Are a is the transmission area (0.3215 cm 2 ) In addition, the ratio of the permeability coefficient (Ps) containing various components to the permeability coefficient (Pc) not containing various components (reference example) was calculated based on the following formula, and this was defined as the Enhancement Ratio (ER). ER = Ps / Pc

[0128] (Cytotoxicity test) After carefully washing the transwell after sampling with PBS, Add 0.5 ml of PBS to the bottom of the trans well (for 24 well plate). 5mL of (3-(4,5-Dimethylthiazol-2-yl)-2,5-Di Replaced with phenyltetrazolium bromide solution (MTT solution). Then, the mixture was incubated at 37°C for 3 hours in the dark. The cells were then detached from the transwell. The 3D cultured human epidermis was transferred to a microtube and 0.3 mL of isopropanol was added. After that, the mixture was incubated in a cool, dark place for 15 hours or more to extract the pigment. The absorbance was measured using a microplate reader from Rona Electric Co., Ltd. (measurement wavelength: 5 Based on the measured values, the cell viability was calculated using the following formula. Cytotoxicity was evaluated.

[0129] Measurement value = [(absorbance at 570 nm for each sample treatment group) - (absorbance at 650 nm for each sample treatment group) m)]-[(absorbance at 570 nm of isopropanol)-(absorbance at 570 nm of isopropanol) absorbance at 650 nm)] Cell viability (%)=100×(measured value of each sample treatment group) / (measured value of PBS treatment group)

[0130] [Table 1]

[0131] The evaluation results regarding the compatibility of permeability and cytotoxicity are shown in Table 1.

[0132] Here, the permeability ratio is the value represented by ER=Ps / Pc as described above. is the value obtained by dividing the ER1 value of the reference comparative example by the ER value of the standard example. Stimulus suppression effect = survival rate ratio = (survival rate of test case / survival rate of control case) The survival rate ratio is × Less than 0.95 △0.95 or more and less than 1.05 ○1.05 or more and less than 1.15 ◎ 1.15 or higher

[0133] The effect of combining permeability and stimulation = (permeability ratio) / (1 / survival rate ratio) Less than ×1 △1 or more and less than 1.05 〇1.05 or more and less than 1.2 ◎ 1.2 or higher

[0134] Compared to the reference sample, 2-methacryloyloxyethyl phosphorylcholine·methacrylate bromide copolymer, dipotassium glycyrrhizinate, pentanediol, or propanediol It was found that the combination of these two ingredients can suppress irritation. On the other hand, when using PEG-1500, both of these were not achieved. stomach.

[0135] Next, the compositions of the examples shown in Table 2 were prepared, and both the permeability and cytotoxicity were evaluated in the same manner as above. The results are also shown in Table 2. [Table 2] Compared to the reference example, the compositions of the examples achieve a better balance between low irritation and good penetration. I realized it could be done.

[0136] (Usability test) Nicotinamide alone is irritating, and 2-methacryloyloxyethyl phosphoryl Choline-Butyl Methacrylate Copolymer and Nicotinamide, or Pentanediol and Nicotinamide The combination of pentanediol, 2-methacrylamide, and methylcellulose reduced irritation. Trimethylsilyloxyethyl phosphorylcholine-butyl methacrylate copolymer, and nicotinic acid In the amide combination, irritation was reduced.

[0137] [Precipitation suppression test] Prepare the compositions in Tables 3 and 4 by conventional methods, and place each sample in a polystyrene weighing dish for 2. These compositions were stored in a thermostatic chamber at 70°C for 15 hours, and the volatile components were After evaporation, the weighing dish was visually inspected for the presence or absence of precipitation.

[0138] <Evaluation criteria> No precipitation △ Slight precipitation × Large precipitation ××The precipitate has evaporated to dryness The results are also shown in Tables 3 to 7. All values ​​in the tables are in mass %.

[0139] [Table 3]

[0140] [Table 4] [Table 5] [Table 6] [Table 7]

[0141] As shown in Tables 3 to 7, the compositions of the comparative examples had a problem of precipitation. On the other hand, it was found that the precipitation was suppressed in the compositions of the examples.

[0142] [Formulation example] The skin topical composition of the present invention was prepared based on the formulation shown in Table 8 below. The values ​​in the table are % by mass.

[0143] [Table 8] JPEG2024156904000012.jpg244168 [Table 9] JPEG2024156904000014.jpg217150 [Table 10] JPEG2024156904000016.jpg248165JPEG2024156904000017.jpg110170 [Table 11] JPEG2024156904000019.jpg242170JPEG2024156904000020.jpg232170 [Table 12] [Table 13] [Table 14] In all formulation examples, a composition for external use on the skin that is pleasant to use can be obtained.

Claims

[Claim 1] (A) nicotinamide; (B) at least one selected from the group consisting of alkanediols having 5 to 10 carbon atoms, propanediols, diglycerols, and hydroxyalkylureas; and (C) a composition for external use on the skin, comprising at least one selected from the group consisting of glycyrrhizinic acid, a salt of glycyrrhizinic acid, and an amphiphilic compound, The amphiphilic compound is one or more selected from the group consisting of a compound represented by the following general formula (I), a phosphorylcholine-containing polymer, and a divalent carboxylate ester: 【Chemistry 1】 (In the formula, Z represents a hydrogen atom or a residue obtained by removing n hydroxy groups from a hydroxy compound having 1 to 30 carbon atoms; AO means an oxyalkylene group having 3 to 4 carbon atoms; EO means an oxyethylene group; BO means an oxyalkylene group having 4 carbon atoms; n is 1 to 9; a, b and c respectively represent the average number of moles of AO, EO and BO added, and are independently 0 to 200. However, a, b and c cannot all be 0. When n is 2 or more, the multiple a's, b's and c's may be the same or different. When Z is a hydrogen atom, n is 1. AO and EO may be added randomly or in the form of a block.

Citation Information

Patent Citations

  • Cosmetic for preventing aging of skin

    JP1998130135A

  • Bleaching agent and vitamin-mixed composition

    JP2004217629A